NEAL KLEIMAN

TitleAdjunct Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address1709 Dryden Road, Suite 900
Houston, TX 77030
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Bou Chaaya RG, Hatab T, Samimi S, Qamar F, Kharsa C, Aoun J, Faza N, Little SH, Atkins MD, Reardon MJ, Kleiman NS, Nagueh SF, Zoghbi WA, Guha A, Zaid S, Goel SS. Prognostic Value of Right Ventricular Afterload in Patients Undergoing Mitral Transcatheter Edge-to-Edge Repair. J Am Heart Assoc. 2024 Apr 03; e033510. PMID: 38567665.
      Citations:    Fields:    
    2. Khan SU, Dani SS, Ganatra S, Ahmed T, Agalan A, Khadke S, Agarwal S, Zaid S, Arshad HB, Zahid S, Shah AR, Goel SS, Kleiman NS. Percutaneous coronary intervention before transcatheter aortic valve implantation: A propensity score matched analysis. Cardiovasc Revasc Med. 2024 Mar 22. PMID: 38553281.
      Citations:    Fields:    
    3. Grubb KJ, Lisko JC, O'Hair D, Merhi W, Forrest JK, Mahoney P, Van Mieghem NM, Windecker S, Yakubov SJ, Williams MR, Chetcuti SJ, Deeb GM, Kleiman NS, Althouse AD, Reardon MJ. Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve?Replacement for Treatment of?Severe Aortic Stenosis. JACC Cardiovasc Interv. 2024 Mar 07. PMID: 38573257.
      Citations:    Fields:    
    4. Khan SU, Kleiman NS. Optimizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Older Adults. JAMA Netw Open. 2024 Mar 04; 7(3):e246951. PMID: 38546651.
      Citations:    Fields:    Translation:Humans
    5. Kleiman NS, Goel SS. The Shape of Things to Come? Is a Trial of Combined Interventional Procedures Necessary in Today's World? Circulation. 2024 03 05; 149(10):744-746. PMID: 38437486.
      Citations:    Fields:    Translation:Humans
    6. Hatab T, Samimi S, Bou Chaaya RG, Qamar F, Kharsa C, Wessly P, Faza N, Little SH, Atkins MD, Reardon MJ, Kleiman NS, Zoghbi WA, Nagueh SF, Zaid S, Goel SS. Echocardiographic Profiling Predicts Clinical Outcomes After Mitral Transcatheter Edge-to-Edge Repair. J Am Heart Assoc. 2024 Mar 05; 13(5):e032784. PMID: 38390821; PMCID: PMC10944065.
      Citations:    Fields:    Translation:Humans
    7. Zaid S, Kleiman NS, Goel SS, Szerlip MI, Mack MJ, Marin-Cuartas M, Mohammadi S, Nazif TM, Unbehaun A, Andreas M, Brinster DR, Robinson NB, Wang L, Ramlawi B, Conradi L, Desai ND, Forrest JK, Bagur R, Nguyen TC, Waksman R, Leroux L, Van Belle E, Grubb KJ, Ahmad HA, Denti P, Modine T, Bapat VN, Kaneko T, Reardon MJ, Tang GHL, Explant-Tavr Registry Investigators OBOT. Impact of transcatheter heart valve type on outcomes of surgical explantation after failed transcatheter aortic valve replacement: the EXPLANT-TAVR international registry. EuroIntervention. 2024 Jan 15; 20(2):e146-e157. PMID: 38224255; PMCID: PMC10786178.
      Citations:    Fields:    Translation:Humans
    8. Bajwa TK, Laham RJ, Khabbaz K, Dauerman HL, Waksman R, Weiss E, Allaqaband S, Badr S, Caskey M, Byrne T, Applegate RJ, Kon ND, Li S, Kleiman NS, Reardon MJ, Chetcuti SJ, Deeb GM. Five-Year Follow-Up from the CoreValve Expanded Use Transcatheter Aortic Valve-in-Surgical Aortic Valve Study. Am J Cardiol. 2024 Mar 01; 214:1-7. PMID: 38110018.
      Citations:    Fields:    Translation:Humans
    9. Zaid S, Wessly P, Hatab T, Faza N, Little SH, Atkins MD, Reardon MJ, Kleiman NS, Zoghbi WA, Goel SS. Intraprocedural Doppler and Invasive Hemodynamic Profiling Predict Clinical Outcomes After Mitral TEER. JACC Cardiovasc Imaging. 2024 Apr; 17(4):454-456. PMID: 38032586.
      Citations: 1     Fields:    
    10. Hatab T, Bou Chaaya RG, Samimi S, Qamar F, Faza N, Little SH, Reardon MJ, Kleiman NS, Zoghbi WA, Guha A, Zaid S, Goel SS. Characteristics and Outcomes of Patients Ineligible for Tricuspid Transcatheter Edge-to-Edge Repair. Struct Heart. 2024 Mar; 8(2):100235. PMID: 38481709; PMCID: PMC10927448.
      Citations:    
    11. Khan SU, Agarwal S, Arshad HB, Akbar UA, Mamas MA, Arora S, Baber U, Goel SS, Kleiman NS, Shah AR. Intravascular imaging guided versus coronary angiography guided percutaneous coronary intervention: systematic review and meta-analysis. BMJ. 2023 11 16; 383:e077848. PMID: 37973170; PMCID: PMC10652093.
      Citations:    Fields:    Translation:Humans
    12. Arora S, Jaswaney R, Khawaja T, Jain A, Khan SU, Gidwani UK, Osman MN, Goel S, Shah AR, Kleiman NS. Outcomes With Intravascular Ultrasound and Optical Coherence Tomography Guidance in Percutaneous Coronary Intervention. Am J Cardiol. 2023 11 15; 207:470-478. PMID: 37844404.
      Citations:    Fields:    Translation:Humans
    13. Kleiman NS. Edge to Edge Mitral Valve Repair After Transcatheter Valve Implantation: Jumping the Gun or Doing What Needs to Be Done? Am J Cardiol. 2024 Jan 01; 210:288-289. PMID: 37844716.
      Citations:    Fields:    
    14. Hatab T, Bou Chaaya RG, Zaid S, Wessly P, Satish P, Villanueva V, Faza N, Little SH, Atkins MD, Reardon MJ, Kleiman NS, Zoghbi WA, Goel SS. Feasibility and Outcomes of Mitral Transcatheter Edge-To-Edge Repair in Patients With Variable Degrees of Mitral Annular Calcification. J Am Heart Assoc. 2023 10 03; 12(19):e031118. PMID: 37753800; PMCID: PMC10727232.
      Citations: 2     Fields:    Translation:Humans
    15. Kragholm K, Abdelkarim O, Sinha A, Zook S, Chao MF, Faza N, Goel S, Reardon M, Kleiman N, Little S, Chang SM. Aortic Valve Calcium Score in Addition to Dobutamine Stress Echocardiography for Low-Flow, Low-Gradient Aortic Stenosis Assessment. J Am Soc Echocardiogr. 2023 Dec; 36(12):1324-1326. PMID: 37586665.
      Citations:    Fields:    Translation:Humans
    16. Hatab T, Zaid S, Wessly P, Reardon MJ, Atkins MD, Faza N, Little SH, Kleiman NS, Goel SS. TAV-in-TAV in Failed Homograft: Redo TAVI in a Patient With 3 Previous Sternotomies. JACC Case Rep. 2023 Sep 20; 22:101973. PMID: 37790767; PMCID: PMC10544086.
      Citations:    
    17. Zaid S, Attizzani GF, Krishnamoorthy P, Yoon SH, Palma Dallan LA, Chetcuti S, Fukuhara S, Grossman PM, Goel SS, Atkins MD, Kleiman NS, Puri R, Bakhtadze B, Byrne T, Ibrahim AW, Grubb KJ, Tully A, Herrmann HC, Faggioni M, Ramlawi B, Khera S, Lerakis S, Dangas GD, Kini AS, Sharma SK, Reardon MJ, Tang GHL. First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR System. JACC Cardiovasc Interv. 2023 07 10; 16(13):1626-1635. PMID: 37438029.
      Citations: 2     Fields:    Translation:Humans
    18. Hatab T, Zaid S, Wessly P, Faza N, Little SH, Atkins MD, Reardon MJ, Kleiman NS, Zoghbi WA, Goel SS. Characteristics and Outcomes of Patients Ineligible for Transcatheter Mitral Valve Replacement. Struct Heart. 2023 Nov; 7(6):100206. PMID: 38046865; PMCID: PMC10692344.
      Citations:    
    19. Hatab T, Zaid S, Toro S, Wessly P, Malahfji M, Faza N, Little SH, Kleiman NS, Reardon MJ, Goel SS. Now You See Me Now You Don't: Subaortic Membrane Causing a Diagnostic Dilemma. JACC Case Rep. 2023 Jul 19; 18:101916. PMID: 37545690; PMCID: PMC10401130.
      Citations:    
    20. Garcia S, Ye J, Webb J, Reardon M, Kleiman N, Goel S, Hatab T, Fam N, Peterson M, Liauw S, Frisoli TM, Bashir H, Paige D, Rock D, Schmidt C, Jollis JG, Kereiakes DJ. Transcatheter Treatment of Native Aortic?Valve Regurgitation: The North American Experience With a Novel Device. JACC Cardiovasc Interv. 2023 08 28; 16(16):1953-1960. PMID: 37212431.
      Citations: 1     Fields:    Translation:HumansAnimals
    21. Zaid S, Atkins MD, Kleiman NS, Reardon MJ, Tang GHL. What's New with TAVR? An Update on Device Technology. Methodist Debakey Cardiovasc J. 2023; 19(3):4-14. PMID: 37213874; PMCID: PMC10198244.
      Citations: 2     Fields:    Translation:Humans
    22. Desai PV, Goel SS, Kleiman NS, Reardon MJ. Transcatheter Aortic Valve Implantation: Long-Term Outcomes and Durability. Methodist Debakey Cardiovasc J. 2023; 19(3):15-25. PMID: 37213878; PMCID: PMC10198228.
      Citations:    Fields:    Translation:Humans
    23. Hatab T, Wessly P, Zaid S, Faza N, Chang SM, Kleiman NS, Little SH, Goel SS. When Echocardiography Is Challenging?in?Localizing Bioprosthetic Aortic?Regurgitation: Dye Don't Lie. JACC Case Rep. 2023 Jun 07; 15:101853. PMID: 37283832; PMCID: PMC10240279.
      Citations:    
    24. Tang GHL, Zaid S, Kleiman NS, Goel SS, Fukuhara S, Marin-Cuartas M, Kiefer P, Abdel-Wahab M, De Backer O, S?ndergaard L, Saha S, Hagl C, Wyler von Ballmoos M, Bhadra O, Conradi L, Grubb KJ, Shih E, DiMaio JM, Szerlip M, Vitanova K, Ruge H, Unbehaun A, Kempfert J, Pirelli L, Kliger CA, Van Mieghem N, Hokken TW, Adrichem R, Modine T, Corona S, Wang L, Petrossian G, Robinson N, Meier D, Webb JG, Cheung A, Ramlawi B, Herrmann HC, Desai ND, Andreas M, Mach M, Waksman R, Schults CC, Ahmad H, Goldberg JB, Geirsson A, Forrest JK, Denti P, Belluschi I, Ben-Ali W, Asgar AW, Taramasso M, Rovin JD, Di Eusanio M, Colli A, Kaneko T, Nazif TN, Leon MB, Bapat VN, Mack MJ, Reardon MJ, Sathananthan J. Explant vs Redo-TAVR After Transcatheter Valve Failure: Mid-Term Outcomes From the EXPLANTORREDO-TAVR International Registry. JACC Cardiovasc Interv. 2023 04 24; 16(8):927-941. PMID: 37100556.
      Citations: 2     Fields:    Translation:Humans
    25. Khan SU, Zahid S, Alkhouli MA, Akbar UA, Zaid S, Arshad HB, Little SH, Reardon MJ, Kleiman NS, Goel SS. An Updated Meta-Analysis on Cerebral Embolic Protection in Patients Undergoing Transcatheter Aortic Valve Intervention Stratified by Baseline Surgical Risk and Device Type. Struct Heart. 2023 Jul; 7(4):100178. PMID: 37520141; PMCID: PMC10382981.
      Citations:    
    26. Forrest JK, Deeb GM, Yakubov SJ, Gada H, Mumtaz MA, Ramlawi B, Bajwa T, Teirstein PS, DeFrain M, Muppala M, Rutkin BJ, Chawla A, Jenson B, Chetcuti SJ, Stoler RC, Poulin MF, Khabbaz K, Levack M, Goel K, Tch?tch? D, Lam KY, Tonino PAL, Ito S, Oh JK, Huang J, Popma JJ, Kleiman N, Reardon MJ, Low Risk Trial Investigators. 3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis. J Am Coll Cardiol. 2023 05 02; 81(17):1663-1674. PMID: 36882136.
      Citations: 6     Fields:    Translation:Humans
    27. Reardon MJ, Chehab B, Smith D, Walton AS, Worthley SG, Manoharan G, Sultan I, Yong G, Harrington K, Mahoney P, Kleiman N, Makkar RR, Fontana G, DeLago A, Ramana RK, Bates N, S?ndergaard L. 30-Day Clinical Outcomes of a Self-Expanding Transcatheter Aortic?Valve: The International PORTICO NG Study. JACC Cardiovasc Interv. 2023 03 27; 16(6):681-689. PMID: 36990558.
      Citations:    Fields:    Translation:Humans
    28. Sammour YM, Spertus JA, Kennedy K, Morrow DA, Daniels LB, Jones P, Alger H, Stevens L, Shah A, Goel SS, de Lemos JA, Hayek SS, Sutton NR, Kleiman NS. Site-level variability in the processes of care and outcomes over time among patients with COVID-19 and myocardial injury: Insights from the American Heart Association's COVID-19 Cardiovascular Disease Registry. Am Heart J Plus. 2023 Mar; 27:100265. PMID: 36779177; PMCID: PMC9894823.
      Citations:    
    29. O'Hair D, Yakubov SJ, Grubb KJ, Oh JK, Ito S, Deeb GM, Van Mieghem NM, Adams DH, Bajwa T, Kleiman NS, Chetcuti S, S?ndergaard L, Gada H, Mumtaz M, Heiser J, Merhi WM, Petrossian G, Robinson N, Tang GHL, Rovin JD, Little SH, Jain R, Verdoliva S, Hanson T, Li S, Popma JJ, Reardon MJ. Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk. JAMA Cardiol. 2023 02 01; 8(2):111-119. PMID: 36515976; PMCID: PMC9857153.
      Citations:    
    30. Gupta T, von Ballmoos MWC, Reardon MJ, Kleiman NS, Goel SS. Ventricular Embolization of Mitral Valve in Valve Rescued With a Second Valve. J Invasive Cardiol. 2023 01; 35(1):E55-E56. PMID: 36588095.
      Citations:    
    31. Khan SU, Kleiman NS. Statin related muscle symptoms: is it time to move on. BMJ. 2022 Dec 20; 379:o2939. PMID: 36593582.
      Citations: 1     Fields:    
    32. Khan SU, Lone AN, Akbar UA, Arshad HB, Arshad A, Arora S, Kaluski E, Aoun J, Goel SS, Shah AR, Kleiman NS. Assessment of Repeat Revascularization in Percutaneous Coronary Intervention Randomized Controlled Trials as a Surrogate for Mortality: A Meta-Regression Analysis. Curr Probl Cardiol. 2023 Apr; 48(4):101555. PMID: 36529233.
      Citations:    Fields:    Translation:Humans
    33. Al Abri Q, El Nihum LI, Hinohara T, Chang SM, Faza NN, Goel SS, Kleiman NS, Wyler von Ballmoos MC, Atkins MD, Reardon MJ. Late Transcatheter Aortic Valve Thrombosis Leading to Cardiogenic?Shock. JACC Case Rep. 2022 Nov 16; 4(22):1459-1463. PMID: 36444179; PMCID: PMC9700056.
      Citations:    
    34. Zaid S, Kleiman NS. Editorial: Minding the Gradient - Valve-in-Valve Transcatheter Aortic Valve Replacement vs. Redo Surgical Aortic Valve Replacements for Surgical Bioprosthetic Valve Failure. Struct Heart. 2022 Nov; 6(6):100113. PMID: 37288127; PMCID: PMC10242556.
      Citations:    
    35. Gupta T, Lin CH, Kleiman NS, Faza NN, Wyler C von Ballmoos M, Little SH, Reardon MJ, Goel SS. Tough Crossing: A Challenging Case of Valve-in-Valve Transcatheter Tricuspid Valve Replacement. Struct Heart. 2023 Jan; 7(1):100105. PMID: 37275312; PMCID: PMC10236865.
      Citations:    
    36. Rizik DG, Rajagopal V, Makkar RR, Bajwa T, Kleiman NS, Linke A, Kereiakes DJ, Waksman R, Thourani VH, Stoler RC, Mishkel GJ, Iyer VS, Buchbinder M, G?tberg M, Bjursten H, Allocco DJ, Reardon MJ. Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical Trial. JAMA Netw Open. 2022 10 03; 5(10):e2238792. PMID: 36301543; PMCID: PMC9614584.
      Citations:    Fields:    Translation:Humans
    37. Van Mieghem NM, Deeb GM, S?ndergaard L, Grube E, Windecker S, Gada H, Mumtaz M, Olsen PS, Heiser JC, Merhi W, Kleiman NS, Chetcuti SJ, Gleason TG, Lee JS, Cheng W, Makkar RR, Crestanello J, George B, George I, Kodali S, Yakubov SJ, Serruys PW, Lange R, Piazza N, Williams MR, Oh JK, Adams DH, Li S, Reardon MJ, SURTAVI Trial Investigators. Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial. JAMA Cardiol. 2022 10 01; 7(10):1000-1008. PMID: 36001335; PMCID: PMC9403849.
      Citations:    
    38. Kleiman NS. Will machine learning help us predict strokes during percutaneous valve procedures? Cardiovasc Revasc Med. 2022 Sep 26. PMID: 36182564.
      Citations:    Fields:    
    39. Isaac T, Gilani S, Kleiman NS. When Prevention is Truly Better than Cure: Contrast-Associated Acute Kidney Injury in Percutaneous Coronary Intervention. Methodist Debakey Cardiovasc J. 2022; 18(4):73-85. PMID: 36132584; PMCID: PMC9461685.
      Citations:    
    40. Jain V, Minhas AMK, Kleiman NS, Arshad HB, Saleh Y, Pandat SS, Dani SS, Goel SS, Faza N, Butt SA, Blankstein R, Cainzos-Achirica M, Nasir K, Khan SU. Cardiac Arrest in Young Adults With Ischemic Heart Disease in the United States, 2004-2018. Curr Probl Cardiol. 2022 Nov; 47(11):101312. PMID: 35839933.
      Citations:    
    41. Kleiman NS, Carroll JD. The Complexities of Redo TAVR. JACC Cardiovasc Interv. 2022 08 08; 15(15):1555-1557. PMID: 35842400.
      Citations:    
    42. Kleiman NS. Editorial: Valve Virtuosi and Pacer Placers - Reducing the Need for Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement. Struct Heart. 2022 Jul; 6(3):100047. PMID: 38304015; PMCID: PMC10831347.
      Citations:    
    43. Kleiman NS, Goel SS. Upping the Transcatheter Edge-to-Edge Repair Game: Patient Selection Based on Newly Described Echocardiographic Measurements. Circ Cardiovasc Interv. 2022 07; 15(7):e012174. PMID: 35686546.
      Citations:    
    44. Ramlawi B, Deeb GM, Yakubov SJ, Markowitz AH, Hughes GC, Kiaii RB, Huang J, Kleiman NS, Reardon MJ. Mechanisms of Death in Low-Risk Patients After Transcatheter or Surgical Aortic Valve Replacement. Cardiovasc Revasc Med. 2022 09; 42:1-5. PMID: 35398007.
      Citations:    
    45. Deeb GM, Reardon MJ, Ramlawi B, Yakubov SJ, Chetcuti SJ, Kleiman NS, Mangi AA, Zahr F, Song HK, Gada H, Mumtaz M, Heiser J, Merhi W, Murrah CP, Noel T, Kirshner M, Byrne T, Ito S, Huang J, Forrest JK. Propensity-Matched 1-Year Outcomes Following Transcatheter Aortic Valve Replacement in Low-Risk Bicuspid and Tricuspid Patients. JACC Cardiovasc Interv. 2022 03 14; 15(5):511-522. PMID: 35272776.
      Citations:    
    46. Forrest JK, Deeb GM, Yakubov SJ, Rovin JD, Mumtaz M, Gada H, O'Hair D, Bajwa T, Sorajja P, Heiser JC, Merhi W, Mangi A, Spriggs DJ, Kleiman NS, Chetcuti SJ, Teirstein PS, Zorn GL, Tadros P, Tch?tch? D, Resar JR, Walton A, Gleason TG, Ramlawi B, Iskander A, Caputo R, Oh JK, Huang J, Reardon MJ. 2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients. J Am Coll Cardiol. 2022 03 08; 79(9):882-896. PMID: 35241222.
      Citations:    
    47. Kleiman NS. Dethroning Contrast Angiography: A Place for Electroanatomic Mapping? JACC Basic Transl Sci. 2022 Feb; 7(2):143-145. PMID: 35257041; PMCID: PMC8897169.
      Citations:    
    48. Chitturi KR, Bhardwaj B, Murtaza G, Karuparthi PR, Faza NN, Goel SS, Reardon MJ, Kleiman NS, Aggarwal K. Clinical Impact of Tricuspid Regurgitation on Transcatheter Edge-to-Edge Mitral Valve Repair for Mitral Regurgitation. Cardiovasc Revasc Med. 2022 08; 41:1-9. PMID: 35398010.
      Citations:    
    49. Gupta T, Tripathi B, Kalra A, Khera S, Sawant A, Nazif TM, Kleiman NS, Kirtane AJ, Goel SS, Bhatt DL, Pershad A, Kodali SK. Trends in 30-Day and 90-Day Readmission Rates After Transcatheter Aortic Valve Implantation. Am J Cardiol. 2022 03 15; 167:167-170. PMID: 35063274.
      Citations:    
    50. Kleiman NS. Getting it Right: Aortic Valve Replacement and the SYNTAX Score. JACC Cardiovasc Interv. 2021 11 22; 14(22):2500-2502. PMID: 34794657.
      Citations:    
    51. Saleh Y, Al-Abcha A, Abdelkarim O, Abdelfattah OM, Abela GS, Hashim H, Goel SS, Kleiman NS. Meta-Analysis Investigating the Role of Optical Coherence Tomography Versus Intravascular Ultrasound in Low-Risk Percutaneous Coronary Intervention. Am J Cardiol. 2022 02 01; 164:136-138. PMID: 34815059.
      Citations:    
    52. Arshad HB, Minhas AMK, Khan SU, Nasir K, Rao N, Thacker S, Butt SA, Faza N, Little SH, von Ballmoos MW, Kleiman NS, Reardon MJ, Kapadia SR, Goel SS. National Trends and Outcomes of Surgical Aortic Valve Replacement With Concomitant Mitral Valve Surgery. Cardiovasc Revasc Med. 2022 07; 40:13-19. PMID: 34801422.
      Citations:    
    53. Sagheer S, Minhas AMK, Arshad HB, Nazir S, Ijaz SH, Ullah W, Khan SU, Kleiman NS, Kapadia SR, Goel SS. Comparative Outcomes of Transcatheter Aortic Valve Implantation and Mitral Transcatheter Edge-to-Edge Repair: Same Versus Different Hospitalization. Am J Cardiol. 2022 02 01; 164:133-135. PMID: 34763828.
      Citations:    
    54. Saleh Y, Al-Abcha A, Abdelkarim O, Abdelnabi M, Almaghraby A, Kleiman NS. Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi. Am J Cardiovasc Drugs. 2022 May; 22(3):231-238. PMID: 34738217.
      Citations:    
    55. Ahmed AI, Han Y, Al Rifai M, Alnabelsi T, Nabi F, Chang SM, Cocker M, Schwemmer C, Ramirez-Giraldo JC, Kleiman NS, Zoghbi WA, Mahmarian JJ, Al-Mallah MH. Prognostic Value of Computed Tomography-Derived Fractional Flow Reserve Comparison With Myocardial Perfusion Imaging. JACC Cardiovasc Imaging. 2022 02; 15(2):284-295. PMID: 34656489.
      Citations:    
    56. Minhas AMK, Ahmed T, Arshad HB, Sagheer S, Ullah W, Kleiman NS, Kapadia SR, Goel SS. Trends in Outcomes of Hospitalized Adults Undergoing Percutaneous Balloon Mitral Valvuloplasty in the United States. Cardiovasc Revasc Med. 2022 06; 39:117-120. PMID: 34756658.
      Citations:    
    57. Dallan LAP, Forrest JK, Reardon MJ, Szeto WY, George I, Kodali S, Kleiman NS, Yakubov SJ, Grubb KJ, Liu F, Baeza C, Attizzani GF. Transcatheter Aortic Valve Replacement With Self-Expandable Supra-Annular Valves for Degenerated Surgical Bioprostheses: Insights From Transcatheter Valve Therapy Registry. J Am Heart Assoc. 2021 09 21; 10(18):e021871. PMID: 34514840; PMCID: PMC8649494.
      Citations:    
    58. Kleiman NS. Monster Under the Bed?: Coronary Access After TAVR. JACC Cardiovasc Interv. 2021 07 26; 14(14):1591-1593. PMID: 34294401.
      Citations:    
    59. Elbadawi A, Elgendy IY, Afify H, Eid M, Hamed M, Abowali HA, Kleiman NS, Reardon MJ, Kapadia SR, Goel SS. Combined Transcatheter Aortic and Mitral Valve Interventions: Insights From a National Database. JACC Cardiovasc Interv. 2021 07 12; 14(13):1505-1507. PMID: 34238564.
      Citations:    
    60. Al-Mallah MH, Ahmed AI, Nabi F, Chang SM, Kleiman NS, Chamsi-Pasha MA, Shah A, Han Y, Zoghbi WA, Mahmarian JJ. Outcomes of patients with moderate-to-severe Ischemia excluded from the ischemia trial. J Nucl Cardiol. 2022 06; 29(3):1100-1105. PMID: 34324083.
      Citations:    
    61. Aoun J, Kleiman NS, Goel SS. Diagnosis and Management of Late-presentation ST-elevation Myocardial Infarction and Complications. Interv Cardiol Clin. 2021 07; 10(3):369-380. PMID: 34053623.
      Citations:    
    62. Arnold SV, Petrossian G, Reardon MJ, Kleiman NS, Yakubov SJ, Wang K, Hermiller J, Harrison JK, Deeb GM, Huang J, Cohen DJ, US CoreValve Investigators. Five-Year Clinical and Quality of Life Outcomes From the CoreValve US Pivotal Extreme Risk Trial. Circ Cardiovasc Interv. 2021 06; 14(6):e010258. PMID: 34092091.
      Citations:    
    63. Nazir S, Gupta T, Ahuja KR, Minhas AMK, Ariss RW, Gupta R, Goel SS, Kleiman NS. Association of Peri-Procedural Major Bleeding With Outcomes in Patients Undergoing Transcatheter Mitral Edge-To-Edge Repair. Am J Cardiol. 2021 08 01; 152:172-174. PMID: 34092365.
      Citations:    
    64. Muntan?-Carol G, Nombela-Franco L, Serra V, Urena M, Amat-Santos I, Vilalta V, Chamandi C, Lhermusier T, Veiga-Fernandez G, Kleiman N, Canadas-Godoy V, Francisco-Pascual J, Himbert D, Castrodeza J, Fernandez-Nofrerias E, Baudinaud P, Mondoly P, Campelo-Parada F, De la Torre Hernandez JM, Pelletier-Beaumont E, Philippon F, Rod?s-Cabau J. Late arrhythmias in patients with new-onset persistent left bundle branch block after transcatheter aortic valve replacement using a balloon-expandable valve. Heart Rhythm. 2021 10; 18(10):1733-1740. PMID: 34082083.
      Citations:    
    65. Gupta T, Faza N, Joseph D, Little SH, Kleiman NS, Wyler von Ballmoos MC, Goel SS. QCA to Guide Treatment of Inter-Clip Mitral Regurgitation Between Two Previously Implanted MitraClips. Cardiovasc Revasc Med. 2022 07; 40S:196-199. PMID: 34059465.
      Citations:    
    66. Elbadawi A, Elzeneini M, Thakker R, Shnoda M, Omer M, Shahin HI, Kapadia SR, Kleiman NS, Reardon MJ, Goel SS. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Combined Chronic Kidney and Liver Disease. JACC Cardiovasc Interv. 2021 05 10; 14(9):1047-1049. PMID: 33958167.
      Citations:    
    67. Elbadawi A, Elzeneini M, Omer M, Megaly M, Abowali H, Mohamed AH, Saleh M, Hamed M, Shahin HI, Kleiman NS, Goel SS. Transcatheter Edge to Edge Repair With MitraClip Among Renal Transplant Recipients. Am J Cardiol. 2021 06 01; 148:178-180. PMID: 33689696.
      Citations:    Fields:    Translation:Humans
    68. Gupta T, Joseph DT, Goel SS, Kleiman NS. Predicting and measuring mortality risk after transcatheter aortic valve replacement. Expert Rev Cardiovasc Ther. 2021 Mar; 19(3):247-260. PMID: 33560150.
      Citations:    Fields:    Translation:Humans
    69. Lisko JC, Babaliaros VC, Khan JM, Kamioka N, Gleason PT, Paone G, Byku I, Tiwana J, McCabe JM, Cherukuri K, Khalil R, Lasorda D, Goel SS, Kleiman NS, Reardon MJ, Daniels DV, Spies C, Mahoney P, Case BC, Whisenant BK, Yadav PK, Condado JF, Koch R, Grubb KJ, Bruce CG, Rogers T, Lederman RJ, Greenbaum AB. Tip-to-Base LAMPOON for Transcatheter Mitral Valve Replacement With a Protected Mitral Annulus. JACC Cardiovasc Interv. 2021 03 08; 14(5):541-550. PMID: 33663781; PMCID: PMC8080374.
      Citations:    
    70. Desai VR, Lee JJ, Sample T, Kleiman NS, Lumsden A, Britz GW. First in Man Pilot Feasibility Study in Extracranial Carotid Robotic-Assisted Endovascular Intervention. Neurosurgery. 2021 02 16; 88(3):506-514. PMID: 33313923.
      Citations: 4     Fields:    Translation:Humans
    71. Muntan?-Carol G, Urena M, Nombela-Franco L, Amat-Santos I, Kleiman N, Munoz-Garcia A, Atienza F, Serra V, Deyell MW, Veiga-Fernandez G, Masson JB, Canadas-Godoy V, Himbert D, Castrodeza J, Elizaga J, Francisco Pascual J, Webb JG, de la Torre Hernandez JM, Asmarats L, Pelletier-Beaumont E, Philippon F, Rod?s-Cabau J. Arrhythmic burden in patients with new-onset persistent left bundle branch block after transcatheter aortic valve replacement: 2-year results of the MARE study. Europace. 2021 02 05; 23(2):254-263. PMID: 33083813.
      Citations:    
    72. Kleiman NS. Is This a Good Time to Revisit the?Tropics?: Platelet Function Testing in Patients With Acute Coronary Syndromes. JACC Cardiovasc Interv. 2021 02 22; 14(4):428-430. PMID: 33516695.
      Citations:    Fields:    Translation:Humans
    73. Lador A, Peterson LE, Swarup V, Schurmann PA, Makkar A, Doshi RN, DeLurgio D, Athill CA, Ellenbogen KA, Natale A, Koneru J, Dave AS, Giorgberidze I, Afshar H, Guthrie ML, Bunge R, Morillo CA, Kleiman NS, Valderr?bano M. Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trial. Heart Rhythm. 2021 07; 18(7):1045-1054. PMID: 33482387; PMCID: PMC8254797.
      Citations: 4     Fields:    Translation:Humans
    74. Kleiman NS, Welt FGP, Truesdell AG, Sherwood M, Kadavath S, Shah PB, Klein LW, Hogan S, Kavinsky C, Rab T, Interventional Section Leadership Council, American College of Cardiology. Should Interventional Cardiologists Super-Subspecialize?: Moving From Patient Selection to Operator Selection. JACC Cardiovasc Interv. 2021 01 11; 14(1):97-100. PMID: 33413871.
      Citations:    Fields:    Translation:Humans
    75. Forrest JK, Ramlawi B, Deeb GM, Zahr F, Song HK, Kleiman NS, Chetcuti SJ, Michelena HI, Mangi AA, Skiles JA, Huang J, Popma JJ, Reardon MJ. Transcatheter Aortic Valve Replacement in Low-risk Patients With Bicuspid Aortic Valve Stenosis. JAMA Cardiol. 2021 01 01; 6(1):50-57. PMID: 33031491; PMCID: PMC7542521.
      Citations:    
    76. Tayal B, Debs D, Nabi F, Malahfji M, Little SH, Reardon M, Zoghbi W, Kleiman N, Shah DJ. Impact of Myocardial Scar on Prognostic Implication of Secondary Mitral Regurgitation in Heart?Failure. JACC Cardiovasc Imaging. 2021 04; 14(4):812-822. PMID: 33341417.
      Citations: 1     Fields:    Translation:Humans
    77. Elbadawi A, Elgendy IY, Tan BE, Saleh M, Khalife WI, Bhimaraj A, Kapadia SR, Kleiman NS, Goel SS. Transcatheter Edge-to-Edge Repair With MitraClip in Systolic Heart?Failure With Ischemic Versus Nonischemic Cardiomyopathy. JACC Cardiovasc Interv. 2020 12 14; 13(23):2818-2819. PMID: 33303125.
      Citations:    
    78. Mumtaz M, Wyler von Ballmoos MC, Deeb GM, Popma JJ, Van Mieghem NM, Kleiman NS, Gleason TG, Chawla A, Hockmuth D, Zorn GL, Tadros P, Li S, Reardon MJ. The Impact of Transfusions on Mortality After Transcatheter or Surgical Aortic Valve Replacement. Ann Thorac Surg. 2021 09; 112(3):778-785. PMID: 33217396.
      Citations:    
    79. Wyler von Ballmoos MC, Reardon MJ, Williams MR, Mangi AA, Kleiman NS, Yakubov SJ, Watson D, Kodali S, George I, Tadros P, Zorn GL, Brown J, Kipperman R, Oh JK, Qiao H, Forrest JK. Three-Year Outcomes With a Contemporary Self-Expanding Transcatheter Valve From the Evolut PRO US Clinical Study. Cardiovasc Revasc Med. 2021 05; 26:12-16. PMID: 33199247.
      Citations: 1     Fields:    Translation:Humans
    80. Aoun J, Assaker JP, Faza N, Kleiman NS, Zacca N, Little SH. Mechanical Prosthetic Aortic Valve Thrombosis Complicated by an Acute Coronary Syndrome During Fibrinolysis. JACC Case Rep. 2020 Nov 18; 2(14):2186-2190. PMID: 34317135; PMCID: PMC8299831.
      Citations:    
    81. Peterson LE, Swarup V, Schurmann PA, Makkar A, Doshi RN, DeLurgio D, Athill CA, Ellenbogen KA, Natale A, Koneru J, Dave AS, Giorgberidze I, Afshar H, Guthrie ML, Bunge R, Morillo CA, Kleiman NS, Valderr?bano M. Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical Trial. JAMA. 2020 10 27; 324(16):1620-1628. PMID: 33107945; PMCID: PMC7592031.
      Citations: 17     Fields:    Translation:Humans
    82. Elbadawi A, Elgendy IY, Megaly M, Ugwu J, Shahin HI, Al-Azizi K, Garcia S, Abbott JD, Gafoor S, Kleiman NS, Goel SS. Trends and Outcomes of Transcatheter Aortic Valve Implantation Among Solid Organ Transplant Recipients. Am J Cardiol. 2021 01 01; 138:122-124. PMID: 33038308.
      Citations:    Fields:    Translation:Humans
    83. Zhan Y, Debs D, Khan MA, Nguyen DT, Graviss EA, Khalaf S, Little SH, Reardon MJ, Nagueh S, Kleiman N, Zoghbi WA, Shah DJ, Qui?ones MA. Natural History of Functional Tricuspid?Regurgitation Quantified by Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2020 09 15; 76(11):1291-1301. PMID: 32912443.
      Citations: 2     Fields:    Translation:Humans
    84. Kleiman NS. Cautionary Tale or Exploratory Trek - Predicting Mortality Using the DAPT Score. Cardiovasc Revasc Med. 2020 12; 21(12):1515-1516. PMID: 33028506.
      Citations:    Fields:    Translation:Humans
    85. Goel SS, Kleiman NS, Zoghbi WA, Reardon MJ, Kapadia SR. Renin-Angiotensin System Blockade in Aortic Stenosis: Implications Before and After Aortic Valve Replacement. J Am Heart Assoc. 2020 09 15; 9(18):e016911. PMID: 32893727; PMCID: PMC7727008.
      Citations: 4     Fields:    Translation:Humans
    86. Goel K, O'Leary JM, Barker CM, Levack M, Rajagopal V, Makkar RR, Bajwa T, Kleiman N, Linke A, Kereiakes DJ, Waksman R, Allocco DJ, Rizik DG, Reardon MJ, Lindman BR. Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement. J Am Heart Assoc. 2020 09; 9(17):e017075. PMID: 32856530; PMCID: PMC7660783.
      Citations: 4     Fields:    Translation:Humans
    87. Yakubov SJ, Van Mieghem NM, Reardon MJ, Serruys PW, Gada H, Mumtaz M, Deeb GM, Kodali S, George I, Windecker S, Kleiman N, Chetcuti SJ, Sanchez C, Dauerman HL, Li S, Popma JJ. Propensity-Matched Comparison of Evolut-R Transcatheter Aortic Valve Implantation With Surgery in Intermediate-Risk Patients (from the SURTAVI Trial). Am J Cardiol. 2020 09 15; 131:82-90. PMID: 32723555.
      Citations: 1     Fields:    Translation:Humans
    88. Shah PB, Welt FGP, Mahmud E, Phillips A, Kleiman NS, Young MN, Sherwood M, Batchelor W, Wang DD, Davidson L, Wyman J, Kadavath S, Szerlip M, Hermiller J, Fullerton D, Anwaruddin S. Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement. Catheter Cardiovasc Interv. 2020 09 01; 96(3):659-663. PMID: 32251546.
      Citations: 16     Fields:    Translation:HumansPHPublic Health
    89. Chitturi KR, Faza NN, Little SH, Kleiman NS, Reardon MJ, Goel SS. Transcatheter Mitral Valve Repair with MitraClip for Severe Mitral Regurgitation and Cardiogenic Shock During the COVID-19 Pandemic. Cardiovasc Revasc Med. 2020 08; 21(8):950-953. PMID: 32473912; PMCID: PMC7244416.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    90. Goel SS, Greenbaum AB, Patel A, Little SH, Parikh R, Wyler von Ballmoos MC, Lumsden AB, Reardon MJ, Kleiman NS. Role of Teleproctoring in Challenging and Innovative Structural Interventions Amid the COVID-19 Pandemic and Beyond. JACC Cardiovasc Interv. 2020 08 24; 13(16):1945-1948. PMID: 32819483; PMCID: PMC7161496.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    91. Shah PB, Welt FGP, Mahmud E, Phillips A, Kleiman NS, Young MN, Sherwood M, Batchelor W, Wang DD, Davidson L, Wyman J, Kadavath S, Szerlip M, Hermiller J, Fullerton D, Anwaruddin S, American College of Cardiology and the Society for Cardiovascular Angiography and Interventions. Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement. JACC Cardiovasc Interv. 2020 06 22; 13(12):1484-1488. PMID: 32250751; PMCID: PMC7270905.
      Citations: 26     Fields:    Translation:HumansCellsPHPublic Health
    92. Blanke P, Leipsic JA, Popma JJ, Yakubov SJ, Deeb GM, Gada H, Mumtaz M, Ramlawi B, Kleiman NS, Sorajja P, Askew J, Meduri CU, Kauten J, Melnitchouk S, Inglessis I, Huang J, Boulware M, Reardon MJ, Evolut Low Risk LTI Substudy Investigators. Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk?Sub-Study. J Am Coll Cardiol. 2020 05 19; 75(19):2430-2442. PMID: 32234463.
      Citations: 12     Fields:    Translation:Humans
    93. Reardon MJ, Kleiman NS. Commentary: Pacemaker requirement with rapid-deployment aortic valves. J Thorac Cardiovasc Surg. 2021 09; 162(3):813-815. PMID: 32164946.
      Citations:    Fields:    Translation:Humans
    94. Van Mieghem NM, Popma JJ, Deeb GM, Yakubov SJ, Serruys PW, Windecker S, Mumtaz M, Gada H, Chetcuti S, Kleiman NS, Kodali S, George I, Teefy P, Kiaii B, Oh JK, Kappetein AP, Chang Y, Mugglin AS, Reardon MJ, SURTAVI Trial Investigators, S?ndergaard L. Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial. JACC Cardiovasc Interv. 2020 02 10; 13(3):323-331. PMID: 32029248.
      Citations: 3     Fields:    Translation:Humans
    95. Faroux L, Nombela-Franco L, Amat-Santos I, Kleiman N, Munoz-Garcia A, Atienza F, Deyell MW, Veiga-Fernandez G, Masson JB, Canadas-Godoy V, Castrodeza J, Elizaga J, Pascual JF, Webb JG, de la Torre JM, Asmarats L, Pelletier-Beaumont E, Couture T, Philippon F, Rodes-Cabau J, Muntan?-Carol G, Urena M, Serra V, Himbert D, Fischer Q, Alm?ndarez M. Late Electrocardiographic Changes in Patients With New-Onset Left Bundle Branch Block Following Transcatheter Aortic Valve Implantation. Am J Cardiol. 2020 03 01; 125(5):795-802. PMID: 31889524.
      Citations: 2     Fields:    Translation:Humans
    96. Panesar SS, Volpi JJ, Lumsden A, Desai V, Kleiman NS, Sample TL, Elkins E, Britz GW. Telerobotic stroke intervention: a novel solution to the care dissemination dilemma. J Neurosurg. 2019 Nov 29; 132(3):971-978. PMID: 31783366.
      Citations: 6     Fields:    Translation:Humans
    97. Garcia-Garcia HM, von Birgelen C, Rademaker-Havinga T, Spitzer E, Kleiman NS, Cohen DJ, Kennedy KF, Camenzind E, Mauri L, Wijns W, Silber S, van Es GA, Serruys PW, Windecker S, Cutlip D, Vranckx P, McFadden EP, Steg PG. Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2019 10 14; 12(19):1954-1962. PMID: 31601389.
      Citations: 10     Fields:    Translation:HumansCells
    98. Burke DA, Kundi H, Almonacid A, O'Neill W, Moses J, Kleiman N, Dixon S, Palacios I, Guzman LA, Ohman EM, Popma JJ, Pinto DS. The Value of Left Ventricular Support in Patients With Reduced Left?Ventricular Function Undergoing Extensive Revascularization: An Analysis From the PROTECT-II Randomized Trial. JACC Cardiovasc Interv. 2019 10 14; 12(19):1985-1987. PMID: 31601396.
      Citations:    Fields:    Translation:Humans
    99. Dauerman HL, Deeb GM, O'Hair DP, Waksman R, Yakubov SJ, Kleiman NS, Chetcuti SJ, Hermiller JB, Bajwa T, Khabbaz K, de Marchena E, Salerno T, Dries-Devlin JL, Li S, Popma JJ, Reardon MJ. Durability and Clinical Outcomes of Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses. Circ Cardiovasc Interv. 2019 10; 12(10):e008155. PMID: 31607151.
      Citations: 7     Fields:    Translation:Humans
    100. Khalid U, Bandeali S, Jones PG, Virani SS, Hira R, Hamzeh I, Chan PS, Kleiman NS, Lakkis N, Alam M. Prescription Patterns of Clopidogrel, Prasugrel, and Ticagrelor After Percutaneous Coronary Intervention With Stent Implantation (from the NCDR PINNACLE Registry). Am J Cardiol. 2019 12 15; 124(12):1807-1812. PMID: 31668345.
      Citations: 2     Fields:    Translation:Humans
    101. Pineda AM, Harrison JK, Kleiman NS, Rihal CS, Kodali SK, Kirtane AJ, Leon MB, Sherwood MW, Manandhar P, Vemulapalli S, Beohar N. Incidence and Outcomes of Surgical?Bailout During TAVR: Insights From the STS/ACC TVT Registry. JACC Cardiovasc Interv. 2019 09 23; 12(18):1751-1764. PMID: 31537276.
      Citations: 5     Fields:    Translation:Humans
    102. Kalra A, Raza S, Hussain M, Shorbaji K, Delozier S, Deo SV, Khera S, Kleiman NS, Reardon MJ, Kolte D, Gupta T, Mustafa R, Bhatt DL, Sabik JF. Aortic Valve Replacement in Bioprosthetic Failure: Insights From The Society of Thoracic Surgeons National Database. Ann Thorac Surg. 2020 11; 110(5):1637-1642. PMID: 31557477.
      Citations: 2     Fields:    Translation:Humans
    103. Elbadawi A, Naqvi SY, Saad M, Elgendy IY, Mahmoud AA, Zainal A, Megaly M, Almahmoud MF, Altaweel A, Kleiman N, Abbott JD. In-Hospital Outcomes with Transfemoral Versus Transapical Access for Transcatheter Aortic Valve Replacement in Patients with Peripheral Arterial Disease. Cardiovasc Revasc Med. 2020 05; 21(5):604-609. PMID: 31757744.
      Citations:    Fields:    Translation:Humans
    104. Khan MR, Kayani WT, Ahmad W, Manan M, Hira RS, Hamzeh I, Jneid H, Virani SS, Kleiman N, Lakkis N, Alam M. Effect of increasing age on percutaneous coronary intervention vs coronary artery bypass grafting in older adults with unprotected left main coronary artery disease: A meta-analysis and meta-regression. Clin Cardiol. 2019 Nov; 42(11):1071-1078. PMID: 31486094; PMCID: PMC6837018.
      Citations: 4     Fields:    Translation:Humans
    105. Reardon MJ, Heijmen RH, Van Mieghem NM, Williams MR, Yakubov SJ, Watson D, Kleiman NS, Conte J, Chawla A, Hockmuth D, Petrossian G, Robinson N, Kappetein AP, Li S, Popma JJ. Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial. JAMA Cardiol. 2019 08 01; 4(8):810-814. PMID: 31215985; PMCID: PMC6584891.
      Citations: 1     Fields:    Translation:Humans
    106. Wyler von Ballmoos MC, Barker CM, Kothapalli PR, Kleiman NS, Reardon MJ. Surgical Bailout for Left Ventricular Outflow Tract Obstruction Following a Complicated Mitral Valve-in-Valve Procedure. Cardiovasc Revasc Med. 2020 11; 21(11):1343-1347. PMID: 31474548.
      Citations:    Fields:    Translation:Humans
    107. Khera S, Kolte D, Deo S, Kalra A, Gupta T, Abbott D, Kleiman N, Bhatt DL, Fonarow GC, Khalique OK, Kodali S, Leon MB, Elmariah S. Derivation and external validation of a simple risk tool to predict 30-day hospital readmissions after transcatheter aortic valve replacement. EuroIntervention. 2019 Jun 20; 15(2):155-163. PMID: 30803938.
      Citations:    
    108. Huded CP, Tuzcu EM, Krishnaswamy A, Mick SL, Kleiman NS, Svensson LG, Carroll J, Thourani VH, Kirtane AJ, Manandhar P, Kosinski AS, Vemulapalli S, Kapadia SR. Association Between Transcatheter Aortic Valve Replacement and Early Postprocedural Stroke. JAMA. 2019 06 18; 321(23):2306-2315. PMID: 31211345; PMCID: PMC6582268.
      Citations: 16     Fields:    Translation:Humans
    109. Peterson LE, Bunge R, Prystash M, Dave AS, Nagueh S, Kleiman NS, Valderr?bano M. Vein of Marshall ethanol infusion for persistent atrial fibrillation: VENUS and MARS clinical trial design. Am Heart J. 2019 09; 215:52-61. PMID: 31279972; PMCID: PMC6692654.
      Citations: 6     Fields:    Translation:Humans
    110. Beg F, Dadu RT, Reardon MJ, Little SH, Kleiman NS, Barker CM. Simultaneous Transfemoral Mitral and Tricuspid Valve in Ring Implantation: First Case Report with Edwards Sapien 3 Valve. Methodist Debakey Cardiovasc J. 2019 Apr-Jun; 15(2):149-151. PMID: 31384379; PMCID: PMC6668740.
      Citations:    Fields:    Translation:Humans
    111. Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O'Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, Adams DH, Teirstein PS, Zorn GL, Forrest JK, Resar J, Walton A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason TG, Oh JK, Boulware MJ, Qiao H, Mugglin AS, Reardon MJ, Evolut Low Risk Trial Investigators, Tch?tch? D. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med. 2019 05 02; 380(18):1706-1715. PMID: 30883053.
      Citations: 490     Fields:    Translation:Humans
    112. Khera S, Villablanca PA, Kolte D, Gupta T, Hasan Khan M, Velagapudi P, Kalra A, Kleiman N, Aronow HD, Abbott JD, Rosenfield K, Drachman DE, Bangalore S, Bhatt DL, Naidu SS. Long-Term Outcomes of Drug-Eluting Stents Versus Bare-Metal Stents in End-Stage Renal Disease Patients on Dialysis: A Systematic Review and Meta-Analysis. Cardiol Rev. 2018 Nov/Dec; 26(6):277-286. PMID: 30157064.
      Citations:    Fields:    Translation:Humans
    113. Durko AP, Reardon MJ, Kleiman NS, Popma JJ, Van Mieghem NM, Gleason TG, Bajwa T, O'Hair D, Brown DL, Ryan WH, Chang Y, De Leon SD, Kappetein AP. Neurological Complications After?Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients. J Am Coll Cardiol. 2018 10 30; 72(18):2109-2119. PMID: 30360820.
      Citations: 5     Fields:    Translation:Humans
    114. Serruys PW, Modolo R, Reardon M, Miyazaki Y, Windecker S, Popma J, Chang Y, Kleiman NS, Lilly S, Amrane H, Boonstra PW, Kappetein AP, Onuma Y, van Mieghem N, S?ndergaard L. One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial. EuroIntervention. 2018 Oct 20; 14(8):877-883. PMID: 29992904.
      Citations:    
    115. Pineda AM, Kevin Harrison J, Kleiman NS, Reardon MJ, Conte JV, O'Hair DP, Chetcuti SJ, Huang J, Yakubov SJ, Popma JJ, Beohar N. Clinical impact of baseline chronic kidney disease in patients undergoing transcatheter or surgical aortic valve replacement. Catheter Cardiovasc Interv. 2019 03 01; 93(4):740-748. PMID: 30341970.
      Citations: 6     Fields:    Translation:Humans
    116. Kleiman NS. Too Thick to Cut With SISRs. Circ Cardiovasc Interv. 2018 10; 11(10):e007365. PMID: 30354643.
      Citations:    Fields:    
    117. Gleason TG, Reardon MJ, Popma JJ, Deeb GM, Yakubov SJ, Lee JS, Kleiman NS, Chetcuti S, Hermiller JB, Heiser J, Merhi W, Zorn GL, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte JV, Mumtaz M, Oh JK, Huang J, Adams DH, CoreValve U.S. Pivotal High Risk Trial Clinical Investigators. 5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients. J Am Coll Cardiol. 2018 12 04; 72(22):2687-2696. PMID: 30249462.
      Citations: 53     Fields:    Translation:Humans
    118. Dadu RT, Xu J, Rehman H, von Ballmoos MW, Barker CM, Reyes M, Ramchandani M, Reul RM, Reardon MJ, Kleiman NS. Optimal positioning of self-expanding valves before deployment decreases paravalvular regurgitation following transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2019 01 01; 93(1):149-155. PMID: 30218488.
      Citations:    Fields:    Translation:Humans
    119. Kleiman NS, Reardon MJ. Does Orientation Matter? JACC Cardiovasc Interv. 2018 09 10; 11(17):1744-1745. PMID: 30121277.
      Citations:    Fields:    Translation:Humans
    120. Hannawi B, Hannawi Y, Kleiman NS. Reticulated Platelets: Changing Focus from Basics to Outcomes. Thromb Haemost. 2018 Sep; 118(9):1517-1527. PMID: 30103247.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    121. Ibrahim H, Rondina MT, Kleiman NS. Von Willebrand factor and the aortic valve: Concepts that are important in the transcatheter aortic valve replacement era. Thromb Res. 2018 10; 170:20-27. PMID: 30092557.
      Citations: 1     Fields:    Translation:Humans
    122. Nombela-Franco L, Amat-Santos I, Munoz-Garcia A, Deyell MW, Veiga-Fernandez G, Masson JB, Canadas-Godoy V, Castrodeza J, Francisco Pascual J, Webb JG, de la Torre JM, Asmarats L, Pelletier-Beaumont E, Rod?s-Cabau J, Urena M, Kleiman N, Atienza F, Serra V, Himbert D, Elizaga J, Philippon F. Arrhythmic Burden as Determined by Ambulatory Continuous Cardiac Monitoring in Patients With New-Onset Persistent Left Bundle Branch Block Following Transcatheter Aortic Valve?Replacement: The MARE Study. JACC Cardiovasc Interv. 2018 08 13; 11(15):1495-1505. PMID: 30031719.
      Citations: 19     Fields:    Translation:Humans
    123. Rehman H, Kleiman NS, Kalra A. Transcatheter valvular interventions in 2017: some things old, some things new! Curr Opin Cardiol. 2018 07; 33(4):363-368. PMID: 29697545.
      Citations:    Fields:    Translation:Humans
    124. Kleiman NS. Never So Simple: Bedside Measurement of Platelet Reactivity and the Risk?of?Stroke After Coronary Stenting. JACC Cardiovasc Interv. 2018 07 09; 11(13):1287-1289. PMID: 29908970.
      Citations:    Fields:    Translation:HumansCells
    125. Kleiman NS. Delayed Coronary Obstruction After?TAVR: A Call for Vigilance. J Am Coll Cardiol. 2018 04 10; 71(14):1525-1527. PMID: 29622158.
      Citations: 4     Fields:    Translation:Humans
    126. Gupta T, Khera S, Kolte D, Goel K, Kalra A, Villablanca PA, Aronow HD, Abbott JD, Fonarow GC, Taub CC, Kleiman NS, Weisz G, Inglessis I, Elmariah S, Rihal CS, Garcia MJ, Bhatt DL. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting: Trends in Utilization and Propensity-Matched Analysis of In-Hospital Outcomes. Circ Cardiovasc Interv. 2018 04; 11(4):e006179. PMID: 29643130.
      Citations: 13     Fields:    Translation:Humans
    127. Kalra A, Avenatti E, Chinnadurai P, Reardon MJ, Kleiman NS, Little SH, Barker CM. Very Late Migration of Balloon-Expandable Transcatheter Aortic Valve. J Invasive Cardiol. 2018 Apr; 30(4):E28-E30. PMID: 29610447.
      Citations:    Fields:    Translation:Humans
    128. Marian AJ, Tan Y, Li L, Chang J, Syrris P, Hessabi M, Rahbar MH, Willerson JT, Cheong BY, Liu CY, Kleiman NS, Bluemke DA, Nagueh SF. Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study. Circ Res. 2018 04 13; 122(8):1109-1118. PMID: 29540445; PMCID: PMC5899034.
      Citations: 14     Fields:    Translation:Humans
    129. Wyler von Ballmoos MC, Barker CM, Reul RM, Dadu R, Ramchandani M, Kleiman NS, Reardon MJ. When to SAVR in the age of TAVR? A perspective on surgical aortic valve replacement in 2018. Cardiovasc Revasc Med. 2018 03; 19(2):139-141. PMID: 29661491.
      Citations: 2     Fields:    Translation:Humans
    130. Kleiman NS. Bleeding Edge Technology: Retroperitoneal Hemorrhage and Its Implications for Transradial Access. Circ Cardiovasc Interv. 2018 02; 11(2):e006320. PMID: 29445003.
      Citations:    Fields:    Translation:Humans
    131. Little SH, Popma JJ, Kleiman NS, Deeb GM, Gleason TG, Yakubov SJ, Checuti S, O'Hair D, Bajwa T, Mumtaz M, Maini B, Hartman A, Katz S, Robinson N, Petrossian G, Heiser J, Merhi W, Moore BJ, Li S, Adams DH, Reardon MJ. Transcatheter aortic valve replacement in patients with severe mitral or tricuspid regurgitation at extreme risk for surgery. J Thorac Cardiovasc Surg. 2018 05; 155(5):1991-1999. PMID: 29429630.
      Citations: 1     Fields:    Translation:Humans
    132. Forrest JK, Mangi AA, Popma JJ, Khabbaz K, Reardon MJ, Kleiman NS, Yakubov SJ, Watson D, Kodali S, George I, Tadros P, Zorn GL, Brown J, Kipperman R, Saul S, Qiao H, Oh JK, Williams MR. Early Outcomes With the Evolut PRO Repositionable Self-Expanding Transcatheter Aortic Valve With Pericardial Wrap. JACC Cardiovasc Interv. 2018 01 22; 11(2):160-168. PMID: 29348010.
      Citations: 24     Fields:    Translation:Humans
    133. Kalra A, Makkar RR, Bhatt DL, Khera S, Kleiman NS, Reardon MJ, Kern MJ. Transcatheter and Doppler waveform correlation in transcatheter aortic valve replacement. Open Heart. 2018; 5(1):e000728. PMID: 29387431; PMCID: PMC5786907.
      Citations:    
    134. Deeb GM, Chetcuti SJ, Yakubov SJ, Patel HJ, Grossman PM, Kleiman NS, Heiser J, Merhi W, Zorn GL, Tadros PN, Petrossian G, Robinson N, Mumtaz M, Gleason TG, Huang J, Conte JV, Popma JJ, Reardon MJ. Impact of Annular Size on Outcomes After Surgical or Transcatheter Aortic Valve Replacement. Ann Thorac Surg. 2018 04; 105(4):1129-1136. PMID: 29307456.
      Citations:    
    135. Feldman TE, Reardon MJ, Rajagopal V, Makkar RR, Bajwa TK, Kleiman NS, Linke A, Kereiakes DJ, Waksman R, Thourani VH, Stoler RC, Mishkel GJ, Rizik DG, Iyer VS, Gleason TG, Rovin JD, Buchbinder M, Meredith IT, Meduri C, Salinger MH, Allocco DJ, Dawkins KD, Tch?tch? D, G?tberg M, Bjursten H. Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial. JAMA. 2018 01 02; 319(1):27-37. PMID: 29297076; PMCID: PMC5833545.
      Citations: 25     Fields:    Translation:Humans
    136. Kleiman N. Stenting: the Latest Frontier in Percutaneous Intervention. Methodist Debakey Cardiovasc J. 2018 Jan-Mar; 14(1):5-6. PMID: 29623166; PMCID: PMC5880560.
      Citations:    Fields:    Translation:Humans
    137. Aggarwal B, Aman W, Jeroudi O, Kleiman NS. Mechanical Circulatory Support in High-Risk Percutaneous Coronary Intervention. Methodist Debakey Cardiovasc J. 2018 Jan-Mar; 14(1):23-31. PMID: 29623169; PMCID: PMC5880556.
      Citations: 1     Fields:    Translation:Humans
    138. O'Hair DP, Bajwa TK, Popma JJ, Watson DR, Yakubov SJ, Adams DH, Sharma S, Robinson N, Petrossian G, Caskey M, Byrne T, Kleiman NS, Zhang A, Reardon MJ. Direct Aortic Access for Transcatheter Aortic Valve Replacement Using a Self-Expanding Device. Ann Thorac Surg. 2018 Feb; 105(2):484-490. PMID: 29174390.
      Citations:    
    139. Bapat V, Rajagopal V, Meduri C, Farivar RS, Walton A, Duffy SJ, Gooley R, Almeida A, Reardon MJ, Kleiman NS, Spargias K, Pattakos S, Ng MK, Wilson M, Adams DH, Leon M, Mack MJ, Chenoweth S, Sorajja P, Intrepid Global Pilot Study Investigators. Early Experience With New Transcatheter?Mitral Valve Replacement. J Am Coll Cardiol. 2018 01 02; 71(1):12-21. PMID: 29102689.
      Citations: 49     Fields:    Translation:Humans
    140. Ibrahim H, Kleiman NS. Platelet pathophysiology, pharmacology, and function in coronary artery disease. Coron Artery Dis. 2017 Nov; 28(7):614-623. PMID: 28644213.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    141. Saad M, Nairooz R, Pothineni NVK, Almomani A, Kovelamudi S, Sardar P, Katz M, Bangalore S, Kleiman NS, Block PC, Abbott JD, Abdel-Wahab M. Long-Term Outcomes With Transcatheter?Aortic?Valve Replacement in?Women?Compared With Men: Evidence From a Meta-Analysis. JACC Cardiovasc Interv. 2018 01 08; 11(1):24-35. PMID: 29055767.
      Citations: 14     Fields:    Translation:Humans
    142. Kleiman NS. In Touch But Out of Time: Aggressive Hospital Discharge and Readmissions After Transcatheter Aortic Valve Replacement. J Am Heart Assoc. 2017 08 21; 6(8). PMID: 28862967; PMCID: PMC5586483.
      Citations:    Fields:    Translation:Humans
    143. Gupta T, Kalra A, Kolte D, Khera S, Villablanca PA, Goel K, Bortnick AE, Aronow WS, Panza JA, Kleiman NS, Abbott JD, Slovut DP, Taub CC, Fonarow GC, Reardon MJ, Rihal CS, Garcia MJ, Bhatt DL. Regional Variation in Utilization, In-hospital Mortality, and Health-Care Resource Use of Transcatheter Aortic Valve Implantation in the United States. Am J Cardiol. 2017 Nov 15; 120(10):1869-1876. PMID: 28865889.
      Citations: 5     Fields:    Translation:Humans
    144. Hira RS, Vemulapalli S, Li Z, McCabe JM, Rumsfeld JS, Kapadia SR, Alam M, Jneid H, Don C, Reisman M, Virani SS, Kleiman NS. Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry. JAMA Cardiol. 2017 08 01; 2(8):846-854. PMID: 28636718; PMCID: PMC5710589.
      Citations: 20     Fields:    Translation:Humans
    145. Kalra A, Uberoi AS, Latib A, Khera S, Little SH, Bhatt DL, Reardon MJ, Kleiman NS, Barker CM. Emerging Transcatheter Options for Tricuspid Regurgitation. Methodist Debakey Cardiovasc J. 2017 Jul-Sep; 13(3):120-125. PMID: 29743996; PMCID: PMC5935195.
      Citations: 1     Fields:    Translation:Humans
    146. Sarkar K, Reardon MJ, Little SH, Barker CM, Kleiman NS. Transcatheter Mitral Valve Replacement for Native and Failed Bioprosthetic Mitral Valves. Methodist Debakey Cardiovasc J. 2017 Jul-Sep; 13(3):142-151. PMID: 29743999; PMCID: PMC5935198.
      Citations: 4     Fields:    Translation:Humans
    147. Khera S, Kolte D, Gupta T, Goldsweig A, Velagapudi P, Kalra A, Tang GHL, Aronow WS, Fonarow GC, Bhatt DL, Aronow HD, Kleiman NS, Reardon M, Gordon PC, Sharaf B, Abbott JD. Association Between Hospital Volume and 30-Day Readmissions Following Transcatheter Aortic Valve Replacement. JAMA Cardiol. 2017 07 01; 2(7):732-741. PMID: 28494061; PMCID: PMC5710612.
      Citations: 17     Fields:    Translation:Humans
    148. Kalra A, Reyes M, Yang EY, Little SH, Nabi F, Barker CM, Ramchandani M, Reul RM, Reardon MJ, Kleiman NS. Transcatheter Aortic Valve Replacement for Perceval Sutureless Aortic Valve Failure. J Invasive Cardiol. 2017 Jun; 29(6):E65-E66. PMID: 28570238.
      Citations: 2     Fields:    Translation:Humans
    149. Kalra A, Rehman H, Ramchandani M, Barker CM, Lawrie GM, Reul RM, Reardon MJ, Kleiman NS. Early Trifecta valve failure: Report of a cluster of cases from a tertiary care referral center. J Thorac Cardiovasc Surg. 2017 10; 154(4):1235-1240. PMID: 28610762.
      Citations: 18     Fields:    Translation:Humans
    150. Deeb GM, Chetcuti SJ, Reardon MJ, Patel HJ, Grossman PM, Schreiber T, Forrest JK, Bajwa TK, O'Hair DP, Petrossian G, Robinson N, Katz S, Hartman A, Dauerman HL, Schmoker J, Khabbaz K, Watson DR, Yakubov SJ, Oh JK, Li S, Kleiman NS, Adams DH, Popma JJ. 1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses. JACC Cardiovasc Interv. 2017 05 22; 10(10):1034-1044. PMID: 28521921.
      Citations: 19     Fields:    Translation:Humans
    151. Sotomi Y, Onuma Y, Collet C, Tenekecioglu E, Virmani R, Kleiman NS, Serruys PW. Bioresorbable Scaffold: The Emerging Reality and Future Directions. Circ Res. 2017 Apr 14; 120(8):1341-1352. PMID: 28408454.
      Citations: 15     Fields:    Translation:Humans
    152. Kleiman NS, Kleiman NJ. At Arm's Length: Radiation Safety During Radial Percutaneous Coronary?Intervention. J Am Coll Cardiol. 2017 05 23; 69(20):2538-2541. PMID: 28330795.
      Citations:    Fields:    Translation:HumansPHPublic Health
    153. Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Mumtaz M, Adams DH, Deeb GM, Maini B, Gada H, Chetcuti S, Gleason T, Heiser J, Merhi W, Oh JK, Olsen PS, Piazza N, Williams M, Windecker S, Yakubov SJ, Grube E, Makkar R, Lee JS, Conte J, Vang E, Nguyen H, Chang Y, Mugglin AS, Serruys PW, Kappetein AP, SURTAVI Investigators, S?ndergaard L, Lange R. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017 04 06; 376(14):1321-1331. PMID: 28304219.
      Citations: 511     Fields:    Translation:Humans
    154. Kalra A, Rehman H, Khera S, Thyagarajan B, Bhatt DL, Kleiman NS, Yeh RW. New-Generation Coronary Stents: Current Data and Future Directions. Curr Atheroscler Rep. 2017 Mar; 19(3):14. PMID: 28220461.
      Citations: 13     Fields:    Translation:Humans
    155. O'Hair DP, Bajwa TK, Chetcuti SJ, Deeb GM, Stoler RC, Hebeler RF, Maini B, Mumtaz M, Kleiman NS, Reardon MJ, Li S, Adams DH, Watson DR, Yakubov SJ, Popma JJ, Petrossian G. One-Year Outcomes of Transcatheter Aortic?Valve Replacement in Patients With?End-Stage Renal Disease. Ann Thorac Surg. 2017 May; 103(5):1392-1398. PMID: 28242075.
      Citations:    Fields:    Translation:Humans
    156. Gaudiani V, Deeb GM, Popma JJ, Adams DH, Gleason TG, Conte JV, Zorn GL, Hermiller JB, Chetcuti S, Mumtaz M, Yakubov SJ, Kleiman NS, Huang J, Reardon MJ. Causes of death from the randomized CoreValve US Pivotal High-Risk Trial. J Thorac Cardiovasc Surg. 2017 06; 153(6):1293-1301.e1. PMID: 28249691.
      Citations: 2     Fields:    Translation:HumansAnimals
    157. Kalra A, Reardon MJ, Kleiman NS. Optimizing Management of Patients With Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: The Importance of Distinguishing Pre-Existing From New Onset Atrial Fibrillation. JACC Cardiovasc Interv. 2017 01 09; 10(1):101-103. PMID: 28057276.
      Citations: 1     Fields:    Translation:Humans
    158. Stolker JM, Cohen DJ, Kennedy KF, Pencina MJ, Arnold SV, Kleiman NS, Spertus JA, EVENT Investigators. Combining clinical and angiographic variables for estimating risk of target lesion revascularization after drug eluting stent placement. Cardiovasc Revasc Med. 2017 Apr - May; 18(3):169-176. PMID: 28041858.
      Citations: 3     Fields:    Translation:Humans
    159. Reardon MJ, Kleiman NS, Adams DH, Yakubov SJ, Coselli JS, Deeb GM, O'Hair D, Gleason TG, Lee JS, Hermiller JB, Chetcuti S, Heiser J, Merhi W, Zorn GL, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte JV, Resar JR, Aharonian V, Pfeffer T, Oh JK, Huang J, Popma JJ. Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less. JAMA Cardiol. 2016 11 01; 1(8):945-949. PMID: 27541162.
      Citations: 14     Fields:    Translation:Humans
    160. Kleiman NS, Reardon MJ. Von Willebrand factor, paravalvular leak, and a new vista for TAVR. J Thorac Dis. 2016 Oct; 8(10):E1337-E1339. PMID: 27867621; PMCID: PMC5107522.
      Citations: 1     
    161. Kleiman NS, Maini BJ, Reardon MJ, Conte J, Katz S, Rajagopal V, Kauten J, Hartman A, McKay R, Hagberg R, Huang J, Popma J, CoreValve Investigators. Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors: A Report From the CoreValve Trials. Circ Cardiovasc Interv. 2016 09; 9(9). PMID: 27601429.
      Citations: 21     Fields:    Translation:Humans
    162. Kleiman NS. The Last Detail: Platelets, Glycoprotein IIb/IIIa Antagonists, and Excipients. JACC Cardiovasc Interv. 2016 08 22; 9(16):1677-9. PMID: 27539686.
      Citations:    Fields:    Translation:Cells
    163. Kalra A, Bhatt DL, Pinto DS, Kirtane AJ, Kapadia SR, Makkar RR, Rihal CS, Kleiman NS, Cutlip DE. Accreditation and funding for a 24-month advanced interventional cardiology fellowship program: A call-to-action for optimal training of the next generation of interventionalists. Catheter Cardiovasc Interv. 2016 Nov 15; 88(6):1010-1015. PMID: 27515241.
      Citations: 1     Fields:    Translation:Humans
    164. Reardon MJ, Kleiman NS. Highway to the heart or one more for the road? The continued life of direct aortic access for transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2016 12; 152(6):1616-1617. PMID: 27566890.
      Citations:    Fields:    
    165. Kleiman NS. Are Immature Platelets Growing Up?: Toward a New Marker of Antiplatelet Drug Resistance. J Am Coll Cardiol. 2016 07 19; 68(3):294-296. PMID: 27417008.
      Citations: 1     Fields:    Translation:Cells
    166. Ibrahim H, Nadipalli S, Usmani S, DeLao T, Green L, Kleiman NS. Detection and quantification of circulating immature platelets: agreement between flow cytometric and automated detection. J Thromb Thrombolysis. 2016 Jul; 42(1):77-83. PMID: 26831482.
      Citations: 9     Fields:    Translation:HumansCells
    167. Kleiman NS. VWF, ADAMTS13, and acute coronary syndromes. Blood. 2016 06 09; 127(23):2788-9. PMID: 27282945.
      Citations: 1     Fields:    Translation:Humans
    168. Skelding KA, Yakubov SJ, Kleiman NS, Reardon MJ, Adams DH, Huang J, Forrest JK, Popma JJ. Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial). Am J Cardiol. 2016 Aug 15; 118(4):560-6. PMID: 27381665.
      Citations: 5     Fields:    Translation:Humans
    169. Deeb GM, Reardon MJ, Chetcuti S, Patel HJ, Grossman PM, Yakubov SJ, Kleiman NS, Coselli JS, Gleason TG, Lee JS, Hermiller JB, Heiser J, Merhi W, Zorn GL, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte J, Resar J, Aharonian V, Pfeffer T, Oh JK, Qiao H, Adams DH, Popma JJ, CoreValve US Clinical Investigators. 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2016 Jun 07; 67(22):2565-74. PMID: 27050187.
      Citations: 72     Fields:    Translation:Humans
    170. Reardon MJ, Kleiman NS. How Many Roads Lead to Rome? JACC Cardiovasc Interv. 2016 Mar 14; 9(5):481-3. PMID: 26965938.
      Citations:    Fields:    Translation:Humans
    171. Gleason TG, Schindler JT, Adams DH, Reardon MJ, Kleiman NS, Caplan LR, Conte JV, Deeb GM, Hughes GC, Chenoweth S, Popma JJ. The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement. J Thorac Cardiovasc Surg. 2016 Jul; 152(1):85-96. PMID: 27085389.
      Citations:    
    172. Ramlawi B, Abu Saleh WK, Al Jabbari O, Barker CM, Kleiman NS, Reardon MJ. Minimally Invasive Repair of Left Ventricular Pseudoaneurysm after Transapical Transcatheter Aortic Valve Replacement. Tex Heart Inst J. 2016 Feb; 43(1):75-7. PMID: 27047291; PMCID: PMC4810592.
      Citations:    
    173. Kleiman NS. What Happens in the Cath Lab Stays in the Cath Lab, or Does It?: Intraprocedural Thrombotic Events in Patients With Acute Coronary Syndromes. JACC Cardiovasc Interv. 2016 Feb 22; 9(4):338-340. PMID: 26803419.
      Citations:    Fields:    Translation:Humans
    174. Kleiman NS, Reardon MJ. Advances in Transcatheter Aortic Valve Replacement. Methodist Debakey Cardiovasc J. 2016 Jan-Mar; 12(1):33-6. PMID: 27127560; PMCID: PMC4847966.
      Citations:    Fields:    Translation:Humans
    175. Reardon MJ, Kleiman NS. Watching a Procedure Evolve: Sequential Findings From the TVT Registry. Ann Thorac Surg. 2016 Feb; 101(2):417-8. PMID: 26652135.
      Citations:    Fields:    Translation:Humans
    176. Reardon MJ, Kleiman NS. Watching a Procedure Evolve: Sequential Findings From the TVT Registry. J Am Coll Cardiol. 2015 Dec 29; 66(25):2824-2826. PMID: 26652231.
      Citations: 1     Fields:    Translation:Humans
    177. Abu Saleh WK, Tang GH, Ahmad H, Cohen M, Undemir C, Lansman SL, Reyes M, Barker CM, Kleiman NS, Reardon MJ, Ramlawi B. Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesis. Catheter Cardiovasc Interv. 2016 Jul; 88(1):135-43. PMID: 26603266.
      Citations: 2     Fields:    Translation:Humans
    178. Zorn GL, Little SH, Tadros P, Deeb GM, Gleason TG, Heiser J, Kleiman NS, Oh JK, Popma JJ, Adams D, Huang J, Reardon MJ. Prosthesis-patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis. J Thorac Cardiovasc Surg. 2016 Apr; 151(4):1014-22, 1023.e1-3. PMID: 26614412.
      Citations:    
    179. Oh JK, Little SH, Abdelmoneim SS, Reardon MJ, Kleiman NS, Lin G, Bach D, Gillam L, Kar B, Coselli J, Sengupta PP, Grewal K, Chang J, Chang Y, Boulware M, Adams DH, Popma JJ, CoreValve U.S. Pivotal Trial Clinical Investigators. Regression of Paravalvular Aortic Regurgitation and Remodeling of Self-Expanding Transcatheter Aortic Valve: An Observation From the CoreValve U.S. Pivotal Trial. JACC Cardiovasc Imaging. 2015 Dec; 8(12):1364-1375. PMID: 26508386.
      Citations: 10     Fields:    Translation:Humans
    180. Abu Saleh WK, Goswami R, Al Jabbari O, Barker C, Kleiman NS, Reardon MJ, Ramlawi B. Transcatheter Treatment of Apicoaortic Conduit Dysfunction. J Card Surg. 2015 Dec; 30(12):885-7. PMID: 26440901.
      Citations: 1     Fields:    Translation:Humans
    181. Yakubov SJ, Adams DH, Watson DR, Reardon MJ, Kleiman NS, Heimansohn D, Hermiller J, Hughes GC, Harrison JK, Coselli J, Diez J, Schreiber T, Gleason TG, Conte J, Deeb GM, Huang J, Oh J, Byrne T, Caskey M, Popma JJ, CoreValve United States Clinical Investigators. 2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery. J Am Coll Cardiol. 2015 Sep 22; 66(12):1327-34. PMID: 26383718.
      Citations: 13     Fields:    Translation:Humans
    182. Reardon MJ, Kleiman NS. At 5 years, transcatheter aortic valve replacement had similar rates of mortality and stroke as surgical aortic valve replacement in high-risk patients. Evid Based Med. 2015 Dec; 20(6):212-3. PMID: 26296815.
      Citations:    Fields:    Translation:Humans
    183. Chaikriangkrai K, Goswami R, Little S, Chang SM, Ramlawi B, Jhun HY, Kleiman N, Reardon MJ, Barker C. Bioprosthetic Mitral Transcatheter Transapical Valve-in-Valve Implantation for Mitral Stenosis in an End-Stage Renal Disease Patient. J Card Surg. 2015 Sep; 30(9):697-700. PMID: 26228701.
      Citations: 1     Fields:    Translation:HumansCells
    184. Abu Saleh WK, Goswami R, Chinnadurai P, Al Jabbari O, Barker CM, Lin CH, Kleiman N, Reardon MJ, Ramlawi B. Direct Aortic Access Transcatheter Aortic Valve Replacement: Three-Dimensional Computed Tomography Planning and Real-Time Fluoroscopic Image Guidance. J Heart Valve Dis. 2015 Jul; 24(4):420-5. PMID: 26897809.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    185. Ramlawi B, Abu Saleh WK, Jabbari OA, Barker C, Lin C, Reyes M, Kleiman NS, Reardon MT. Short-Term Outcomes with Direct Aortic Access for Transcatheter Aortic Valve Replacement. J Heart Valve Dis. 2015 Jul; 24(4):426-32. PMID: 26897810.
      Citations: 2     Fields:    Translation:Humans
    186. Kleiman NS, Kolandaivelu K. Expanding the Roster: Developing New Inhibitors of Intravascular Thrombosis. J Am Coll Cardiol. 2015 Jun 09; 65(22):2416-9. PMID: 26046735.
      Citations: 1     Fields:    Translation:Humans
    187. Reardon MJ, Adams DH, Kleiman NS, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Lee JS, Hermiller JB, Chetcuti S, Heiser J, Merhi W, Zorn GL, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte JV, Resar JR, Aharonian V, Pfeffer T, Oh JK, Qiao H, Popma JJ. 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2015 Jul 14; 66(2):113-21. PMID: 26055947.
      Citations: 93     Fields:    Translation:Humans
    188. Kleiman NS. Is it time to join the cult? Radial access and percutaneous coronary intervention. Circ Cardiovasc Interv. 2015 Jun; 8(6):e002745. PMID: 26056250.
      Citations:    Fields:    Translation:Humans
    189. Ibrahim H, Barker CM, Reardon MJ, Kleiman NS. Suicide left ventricle due to conduction disturbance following transcatheter aortic valve replacement and reversal with restoration of sinus rhythm: is there life after death? J Invasive Cardiol. 2015 Jun; 27(6):E107-9. PMID: 26028658.
      Citations: 2     Fields:    Translation:Humans
    190. Goswami R, Colin B, Jackson M, Kleiman N, Little S. Transesophageal echocardiography-guided percutaneous intervention for a mitral valve leaflet perforation. JACC Cardiovasc Interv. 2015 Apr 27; 8(5):754-5. PMID: 25946451.
      Citations: 1     Fields:    Translation:Humans
    191. Osnabrugge RL, Arnold SV, Reynolds MR, Magnuson EA, Wang K, Gaudiani VA, Stoler RC, Burdon TA, Kleiman N, Reardon MJ, Adams DH, Popma JJ, Cohen DJ, CoreValve U.S. Trial Investigators. Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial. JACC Cardiovasc Interv. 2015 Feb; 8(2):315-323. PMID: 25700755; PMCID: PMC4362674.
      Citations: 27     Fields:    Translation:HumansCTClinical Trials
    192. Ibrahim H, Schutt RC, Hannawi B, DeLao T, Barker CM, Kleiman NS. Association of immature platelets with adverse cardiovascular outcomes. J Am Coll Cardiol. 2014 Nov 18-25; 64(20):2122-9. PMID: 25457402.
      Citations: 25     Fields:    Translation:HumansCells
    193. Reardon MJ, Adams DH, Coselli JS, Deeb GM, Kleiman NS, Chetcuti S, Yakubov SJ, Heimansohn D, Hermiller J, Hughes GC, Harrison JK, Khabbaz K, Tadros P, Zorn GL, Merhi W, Heiser J, Petrossian G, Robinson N, Maini B, Mumtaz M, Lee JS, Gleason TG, Resar J, Conte J, Watson D, Chenoweth S, Popma JJ, CoreValve US Clinical Investigators. Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgery. J Thorac Cardiovasc Surg. 2014 Dec; 148(6):2869-76.e1-7. PMID: 25152474.
      Citations: 6     Fields:    Translation:Humans
    194. Kassi M, Lopez J, Barker C, Trerotola S, Kleiman N, Kurrelmeyer K. Case report: It wasn't cupid: multimodality imaging of inferior vena cava filter fracture with strut migration to the interventricular septum. Methodist Debakey Cardiovasc J. 2014 Jul-Sep; 10(3):198-200. PMID: 25574350; PMCID: PMC4280247.
      Citations: 2     Fields:    Translation:Humans
    195. Pershad A, Fraij G, Massaro JM, David SW, Kleiman NS, Denktas AE, Wilson BH, Dixon SR, Ohman EM, Douglas PS, Moses JW, O'Neill WW. Comparison of the use of hemodynamic support in patients =80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study). Am J Cardiol. 2014 Sep 01; 114(5):657-64. PMID: 25037676.
      Citations:    Fields:    Translation:Humans
    196. Lincoff AM, Roe M, Aylward P, Galla J, Rynkiewicz A, Guetta V, Zelizko M, Kleiman N, White H, McErlean E, Erlinge D, Laine M, Dos Santos Ferreira JM, Goodman S, Mehta S, Atar D, Suryapranata H, Forster T, Fernandez-Ortiz A, Schoors D, Belli G, Brennan D, Bell G, Krucoff M, PROTECTION AMI Investigators, Jensen SE, Radke P. Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial. Eur Heart J. 2014 Oct 01; 35(37):2516-23. PMID: 24796339.
      Citations: 34     Fields:    Translation:HumansCTClinical Trials
    197. Bangalore S, Pencina MJ, Kleiman NS, Cohen DJ. Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry. Circ Cardiovasc Interv. 2014 Jun; 7(3):365-73. PMID: 24736878.
      Citations: 3     Fields:    Translation:Humans
    198. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK, U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014 May 08; 370(19):1790-8. PMID: 24678937.
      Citations: 483     Fields:    Translation:Humans
    199. Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleiman NS, Heimansohn D, Hermiller J, Hughes GC, Harrison JK, Coselli J, Diez J, Kafi A, Schreiber T, Gleason TG, Conte J, Buchbinder M, Deeb GM, Serruys PW, Chenoweth S, Oh JK, CoreValve United States Clinical Investigators, Carabello B. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014 May 20; 63(19):1972-81. PMID: 24657695.
      Citations: 184     Fields:    Translation:HumansCTClinical Trials
    200. Kleiman NS. Are we there yet? deciding when it is safe (and wise) to stop clopidogrel after stent implantation. J Interv Cardiol. 2014 Apr; 27(2):127-30. PMID: 24617441.
      Citations:    Fields:    Translation:Humans
    201. Ramlawi B, Bedeir K, Barker C, Lin CH, Kleiman N, Reardon M. Direct aortic and subclavian access for transcatheter aortic valve replacement: decision making and technique. J Thorac Cardiovasc Surg. 2014 Jul; 148(1):353-6. PMID: 24655905.
      Citations: 1     Fields:    Translation:Humans
    202. Dasari TW, Cohen DJ, Kleiman NS, Keyes MJ, Yen CH, Hanna EB, Saucedo JF. Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry). Am J Cardiol. 2014 Feb 15; 113(4):621-5. PMID: 24342762.
      Citations: 6     Fields:    Translation:Humans
    203. Cohen MG, Ghatak A, Kleiman NS, Naidu SS, Massaro JM, Kirtane AJ, Moses J, Magnus Ohman E, Palacios IF, Heldman AW, Popma JJ, O'Neill WW, D?av?k V. Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT ?? study. Catheter Cardiovasc Interv. 2014 Jun 01; 83(7):1057-64. PMID: 24174321.
      Citations: 10     Fields:    Translation:Humans
    204. Bangalore S, Pencina MJ, Kleiman NS, Cohen DJ. Prognostic implications of procedural vs spontaneous myocardial infarction: results from the Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry. Am Heart J. 2013 Dec; 166(6):1027-34. PMID: 24268217.
      Citations: 6     Fields:    Translation:Humans
    205. Estep JD, Cordero-Reyes AM, Bhimaraj A, Trachtenberg B, Khalil N, Loebe M, Bruckner B, Orrego CM, Bismuth J, Kleiman NS, Torre-Amione G. Percutaneous placement of an intra-aortic balloon pump in the left axillary/subclavian position provides safe, ambulatory long-term support as bridge to heart transplantation. JACC Heart Fail. 2013 Oct; 1(5):382-8. PMID: 24621970.
      Citations: 28     Fields:    Translation:Humans
    206. Angiolillo DJ, Ferreiro JL, Jakubowski JA, Winters KJ, Effron MB, Duvvuru S, Costigan TM, Sundseth S, Walker JR, Saucedo JF, Kleiman NS, Varenhorst C, Braun O?. Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways. Thromb Haemost. 2013 Dec; 110(6):1223-31. PMID: 24009042.
      Citations: 7     Fields:    Translation:HumansCells
    207. Chaikriangkrai K, Polsani V, Wei L, Kleiman N, Chang SM. Stenting of a left main coronary artery compressed by a dilated main pulmonary artery. Catheter Cardiovasc Interv. 2013 Nov 01; 82(5):E684-7. PMID: 23804497.
      Citations: 2     Fields:    Translation:Humans
    208. Vavalle JP, Clare R, Chiswell K, Rao SV, Petersen JL, Kleiman NS, Mahaffey KW, Wang TY. Prognostic significance of bleeding location and severity among patients with acute coronary syndromes. JACC Cardiovasc Interv. 2013 Jul; 6(7):709-17. PMID: 23866183; PMCID: PMC3884698.
      Citations: 7     Fields:    Translation:Humans
    209. Alam M, Virani SS, Shahzad SA, Siddiqui S, Siddiqui KH, Mumtaz SA, Kleiman NS, Coselli JS, Lakkis NM, Jneid H. Comparison by meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with a mean age of =70 years. Am J Cardiol. 2013 Sep 01; 112(5):615-22. PMID: 23726179.
      Citations: 8     Fields:    Translation:Humans
    210. Gordon PC, Cohen DJ, Kleiman NS, Montgomery JA, Semder CA, Kennedy KF, Keyes MJ, Piana RN, EVENT Investigators. In-hospital and one year outcomes with drug-eluting versus bare metal stents in large native coronary arteries: a report from the Evaluation of Drug-Eluting Stents and Ischemic Events registry. Catheter Cardiovasc Interv. 2013 Oct 01; 82(4):E356-64. PMID: 22511502.
      Citations:    Fields:    Translation:Humans
    211. Fatemi O, Torguson R, Chen F, Ahmad S, Badr S, Satler LF, Pichard AD, Kleiman NS, Waksman R. Red cell distribution width as a bleeding predictor after percutaneous coronary intervention. Am Heart J. 2013 Jul; 166(1):104-9. PMID: 23816028.
      Citations: 10     Fields:    Translation:HumansCells
    212. Alam M, Bandeali SJ, Kayani WT, Ahmad W, Shahzad SA, Jneid H, Birnbaum Y, Kleiman NS, Coselli JS, Ballantyne CM, Lakkis N, Virani SS. Comparison by meta-analysis of mortality after isolated coronary artery bypass grafting in women versus men. Am J Cardiol. 2013 Aug 01; 112(3):309-17. PMID: 23642381.
      Citations: 25     Fields:    Translation:Humans
    213. Lopes RD, White JA, Atar D, Keltai M, Kleiman NS, White HD, Widimsky P, Zeymer U, Giugliano RP, Tricoci P, Braunwald E, Bode C, Ohman EM, Armstrong PW, Newby LK. Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes. Int J Cardiol. 2013 Oct 03; 168(3):2510-7. PMID: 23578889.
      Citations: 7     Fields:    Translation:Humans
    214. Fatemi O, Paranilam J, Rainow A, Kennedy K, Choi J, Cutlip D, Pencina M, Berger PB, Cohen DJ, Kleiman NS. Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention. J Thromb Thrombolysis. 2013 Jan; 35(1):57-64. PMID: 22752404.
      Citations: 15     Fields:    Translation:HumansCellsCTClinical Trials
    215. Alam M, Huang HD, Shahzad SA, Kar B, Virani SS, Rogers PA, Paniagua D, Bozkurt B, Palacios I, Kleiman NS, Jneid H. Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era--an aggregate data meta-analysis of 11,148 patients. Circ J. 2013; 77(2):372-82. PMID: 23123552.
      Citations: 11     Fields:    Translation:Humans
    216. Stolker JM, Cohen DJ, Kennedy KF, Pencina MJ, Lindsey JB, Mauri L, Cutlip DE, Kleiman NS, Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) Investigators. Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year. Circ Cardiovasc Interv. 2012 Dec; 5(6):772-82. PMID: 23093553.
      Citations: 16     Fields:    Translation:Humans
    217. O'Neill WW, Kleiman NS, Moses J, Henriques JP, Dixon S, Massaro J, Palacios I, Maini B, Mulukutla S, Popma J, Douglas PS, Ohman M, Dzav?k V. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation. 2012 Oct 02; 126(14):1717-27. PMID: 22935569.
      Citations: 149     Fields:    Translation:Humans
    218. Alviar CL, Tellez A, Wang M, Potts P, Smith D, Tsui M, Budzynski W, Raizner AE, Kleiman NS, Lev EI, Granada JF, Kaluza GL. Low-dose sirolimus-eluting hydroxyapatite coating on stents does not increase platelet activation and adhesion ex vivo. J Thromb Thrombolysis. 2012 Jul; 34(1):91-8. PMID: 22350685.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    219. Caputo RP, Goel A, Pencina M, Cohen DJ, Kleiman NS, Yen CH, Waksman R, Tolerico P, Dhar G, Gordon P, Bach RG, Lopez JJ. Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry). Am J Cardiol. 2012 Aug 01; 110(3):350-5. PMID: 22560770.
      Citations: 9     Fields:    Translation:Humans
    220. Tolerico PH, Cohen DJ, Kleiman NS, Berger PB, Brilakis ES, Piana RN, Shammo S, Keyes MJ, Kennedy KF, Massaro JM, Saucedo JF, EVENT Investigators. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry. Catheter Cardiovasc Interv. 2012 Dec 01; 80(7):1127-36. PMID: 22431166.
      Citations:    Fields:    Translation:Humans
    221. Maini B, Naidu SS, Mulukutla S, Kleiman N, Schreiber T, Wohns D, Dixon S, Rihal C, Dave R, O'Neill W. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry. Catheter Cardiovasc Interv. 2012 Nov 01; 80(5):717-25. PMID: 22105829.
      Citations: 28     Fields:    Translation:Humans
    222. Alam M, Bandeali SJ, Virani SS, Jneid HM, Shahzad SA, Ramanathan KB, Kar B, Kleiman NS, Lakkis N. Clinical outcomes of percutaneous interventions in saphenous vein grafts using drug-eluting stents compared to bare-metal stents: a comprehensive meta-analysisof all randomized clinical trials. Clin Cardiol. 2012 May; 35(5):291-6. PMID: 22488047; PMCID: PMC6652335.
      Citations: 2     Fields:    Translation:Humans
    223. Kleiman N. Introduction to transcatheter aortic valve implantation. Methodist Debakey Cardiovasc J. 2012 Apr-Jun; 8(2):2-3. PMID: 22891119; PMCID: PMC3405800.
      Citations:    Fields:    Translation:Humans
    224. Kleiman N. Room considerations with TAVR. Methodist Debakey Cardiovasc J. 2012 Apr-Jun; 8(2):19-21. PMID: 22891123; PMCID: PMC3405801.
      Citations: 1     Fields:    Translation:Humans
    225. Kleiman NS. Grabbing the horns of a dilemma: the duration of dual antiplatelet therapy after stent implantation. Circulation. 2012 Apr 24; 125(16):1967-70. PMID: 22438531.
      Citations: 3     Fields:    Translation:Humans
    226. Novack V, Pencina M, Cohen DJ, Kleiman NS, Yen CH, Saucedo JF, Berger PB, Cutlip DE. Troponin criteria for myocardial infarction after percutaneous coronary intervention. Arch Intern Med. 2012 Mar 26; 172(6):502-8. PMID: 22371874.
      Citations: 26     Fields:    Translation:Humans
    227. Win HK, Polsani V, Chang SM, Kleiman NS. Stent-assisted coil embolization of a large fusiform aneurysm of proximal anterior descending artery: novel treatment for coronary aneurysms. Circ Cardiovasc Interv. 2012 Feb 01; 5(1):e3-5. PMID: 22338006.
      Citations: 6     Fields:    Translation:Humans
    228. Ibrahim H, Nadipalli S, DeLao T, Guthikonda S, Kleiman NS. Immature platelet fraction (IPF) determined with an automated method predicts clopidogrel hyporesponsiveness. J Thromb Thrombolysis. 2012 Feb; 33(2):137-42. PMID: 22198802.
      Citations: 19     Fields:    Translation:HumansCells
    229. Stolker JM, Cohen DJ, Lindsey JB, Kennedy KF, Kleiman NS, Marso SP. Mode of death after contemporary percutaneous coronary intervention: a report from the Evaluation of Drug Eluting Stents and Ischemic Events registry. Am Heart J. 2011 Nov; 162(5):914-21. PMID: 22093209.
      Citations: 3     Fields:    Translation:Humans
    230. Lei Y, Magnuson EA, Chan PS, Stolker JM, Kennedy KF, Kleiman NS, Cohen DJ, EVENT Registry Investigators, Venkitachalam L. Survival benefit with drug-eluting stents in observational studies: fact or artifact? Circ Cardiovasc Qual Outcomes. 2011 Nov 01; 4(6):587-94. PMID: 21988921.
      Citations: 8     Fields:    Translation:Humans
    231. Lindsey JB, Kennedy KF, Stolker JM, Gilchrist IC, Mukherjee D, Marso SP, Pencina MJ, Kleiman NS, Cohen DJ. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry. Circ Cardiovasc Interv. 2011 Oct 01; 4(5):474-80. PMID: 21972402.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    232. Bangalore S, Cohen DJ, Kleiman NS, Regev-Beinart T, Rao SV, Pencina MJ, Mauri L, EVENT Registry Investigators, Boston, MA. Bleeding risk comparing targeted low-dose heparin with bivalirudin in patients undergoing percutaneous coronary intervention: results from a propensity score-matched analysis of the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry. Circ Cardiovasc Interv. 2011 Oct 01; 4(5):463-73. PMID: 21972401.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    233. Buergler JM, Kleiman NS. Balancing hemostasis and thrombosis in interventional vascular medicine and surgery. Methodist Debakey Cardiovasc J. 2011 Oct-Dec; 7(4):19-23. PMID: 22143472.
      Citations:    Fields:    Translation:Humans
    234. Kleiman NS. Bringing it all together: integration of physiology with anatomy during cardiac catheterization. J Am Coll Cardiol. 2011 Sep 13; 58(12):1219-21. PMID: 21903053.
      Citations: 12     Fields:    Translation:Humans
    235. Venkitachalam L, Lei Y, Stolker JM, Mahoney EM, Amin AP, Lindsey JB, Kennedy KF, Pencina MJ, Lopez JJ, Kleiman NS, Cohen DJ, EVENT Registry Investigators. Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry. Circulation. 2011 Aug 30; 124(9):1028-37. PMID: 21844081.
      Citations: 9     Fields:    Translation:Humans
    236. French JK, Armstrong PW, Cohen E, Kleiman NS, O'Connor CM, Hellkamp AS, Stebbins A, Holmes DR, Hochman JS, Granger CB, Mahaffey KW. Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction". Am Heart J. 2011 Jul; 162(1):89-97. PMID: 21742094.
      Citations: 6     Fields:    Translation:Humans
    237. Amin AP, Kennedy KF, Pencina M, Berger P, Piana RN, Lopez J, Kleiman N, Cohen DJ, EVENT Investigators. Effect of clopidogrel pretreatment on ischemic complications of percutaneous coronary intervention among bivalirudin-treated patients (from the EVENT registry). Am J Cardiol. 2011 Jun 15; 107(12):1751-6. PMID: 21640216.
      Citations: 2     Fields:    Translation:Humans
    238. Rodriguez G, Starr AZ, Czernuszewicz GZ, Manhas A, Alhariri A, Willerson JT, Reist CJ, Pieper K, Mahaffey KW, Marian AJ, Kleiman NS. Determinants of plasma vitamin D levels in patients with acute coronary syndromes. Eur J Clin Invest. 2011 Dec; 41(12):1299-309. PMID: 21615392.
      Citations: 3     Fields:    Translation:Humans
    239. Mahaffey KW, Pieper KS, Lokhnygina Y, Califf RM, Antman EM, Kleiman NS, Goodman SG, White HD, Rao SV, Hochman JS, Cohen M, Col JJ, Roe MT, Ferguson JJ, SYNERGY Investigators. The impact of postrandomization crossover of therapy in acute coronary syndromes care. Circ Cardiovasc Qual Outcomes. 2011 Mar; 4(2):211-9. PMID: 21304094.
      Citations: 1     Fields:    Translation:Humans
    240. Brilakis ES, Cohen DJ, Kleiman NS, Pencina M, Nassif D, Saucedo J, Piana RN, Banerjee S, Keyes MJ, Yen CH, Berger PB. Incidence and clinical outcome of minor surgery in the year after drug-eluting stent implantation: results from the Evaluation of Drug-Eluting Stents and Ischemic Events Registry. Am Heart J. 2011 Feb; 161(2):360-6. PMID: 21315220.
      Citations: 5     Fields:    Translation:Humans
    241. Becker RC, Mahaffey KW, Yang H, Marian AJ, Furman MI, Michael Lincoff A, Hazen SL, Petersen JL, Reist CJ, Kleiman NS, SYNERGY Investigators. Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome. J Thromb Thrombolysis. 2011 Feb; 31(2):146-53. PMID: 21086021.
      Citations: 3     Fields:    Translation:HumansCells
    242. Mahaffey KW, Wampole JL, Stebbins A, Berdan LG, McAfee D, Rorick TL, French JK, Kleiman NS, O'Connor CM, Cohen EA, Granger CB, Armstrong PW, APEX-AMI Investigators. Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Contemp Clin Trials. 2011 Mar; 32(2):178-87. PMID: 21220052.
      Citations: 4     Fields:    Translation:Humans
    243. Kleiman N, Reardon MJ. TAVI: transcatheter aortic valve implantation. Methodist Debakey Cardiovasc J. 2011 Jan-Mar; 7(1):49-52. PMID: 21490555.
      Citations:    Fields:    Translation:Humans
    244. Giugliano RP, Pollack CV, Brogan GX, Cohen M, Diercks DB, Grines CL, Henry TD, Kleiman NS. Acute coronary syndromes: from the emergency department to the catheterization laboratory-integrating evidence from recent ACS/NSTEMI trials into clinical practice: an evidence-based review of recent clinical trial results and report on a roundtable discussion. J Interv Cardiol. 2011 Apr; 24(2):119-36. PMID: 21114529.
      Citations:    Fields:    Translation:Humans
    245. Mangalpally KK, Kleiman NS. The safety of clopidogrel. Expert Opin Drug Saf. 2011 Jan; 10(1):85-95. PMID: 21091040.
      Citations: 4     Fields:    Translation:Humans
    246. Mangalpally KK, Siqueiros-Garcia A, Vaduganathan M, Dong JF, Kleiman NS, Guthikonda S. Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro. J Thromb Thrombolysis. 2010 Oct; 30(3):251-62. PMID: 20502945.
      Citations: 28     Fields:    Translation:HumansCells
    247. Lopez JJ, Keyes MJ, Nathan S, Piana R, Pencina M, Dhar G, Marso S, Rao S, Shammo S, Marquardt W, Cohen DJ, Kleiman NS. Rapid adoption of drug-eluting stents: clinical practices and outcomes from the early drug-eluting stent era. Am Heart J. 2010 Oct; 160(4):767-74. PMID: 20934573.
      Citations: 2     Fields:    Translation:Humans
    248. Berger PB, Kleiman NS, Pencina MJ, Hsieh WH, Steinhubl SR, Jeremias A, Sonel A, Browne K, Barseness G, Cohen DJ, EVENT Investigators. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv. 2010 Sep; 3(9):920-7. PMID: 20850090.
      Citations: 26     Fields:    Translation:Humans
    249. Stolker JM, Kennedy KF, Lindsey JB, Marso SP, Pencina MJ, Cutlip DE, Mauri L, Kleiman NS, Cohen DJ, EVENT Investigators. Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry. Circ Cardiovasc Interv. 2010 Aug; 3(4):327-34. PMID: 20606136.
      Citations: 23     Fields:    Translation:Humans
    250. Kleiman NS. PLATO study of ticagrelor versus clopidogrel in patients with high-risk acute coronary syndromes. Curr Cardiol Rep. 2010 Jul; 12(4):283-5. PMID: 20432073.
      Citations:    Fields:    
    251. Kleiman NS. Resistance or resistors? Has Ohm's law come to antiplatelet therapy? Am Heart J. 2010 May; 159(5):713-5. PMID: 20435177.
      Citations:    Fields:    Translation:Humans
    252. Cohen M, Levine GN, Pieper KS, Lan L, Antman EM, Aylward PE, White HD, Kleiman NS, Califf RM, Mahaffey KW, SYNERGY Trial Investigators. Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial. Catheter Cardiovasc Interv. 2010 May 01; 75(6):928-35. PMID: 20432399.
      Citations: 3     Fields:    Translation:Humans
    253. Rao SV, Melloni C, Myles-Dimauro S, Broderick S, Kosinski AS, Kleiman NS, Tanguay JF, Chandna H, Gammon R, Rivera E, Alexander JH, Fier I, Roach J, Becker RC, EMINENCE Investigators, Dzav?k V. Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial. Circulation. 2010 Apr 20; 121(15):1713-21. PMID: 20368520.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    254. Lev EI, Solodky A, Harel N, Mager A, Brosh D, Assali A, Roller M, Battler A, Kleiman NS, Kornowski R. Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation. J Am Coll Cardiol. 2010 Jan 12; 55(2):114-21. PMID: 20117379.
      Citations: 25     Fields:    Translation:Humans
    255. Granada JF, Alviar CL, Wallace-Bradley D, Osteen M, Dave B, Tellez A, Win HK, Kleiman NS, Kaluza GL, Lev EI. Patterns of activation and deposition of platelets exposed to the polymeric surface of the paclitaxel eluting stent. J Thromb Thrombolysis. 2010 Jan; 29(1):60-9. PMID: 19466381.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    256. Harrington RA, Stone GW, McNulty S, White HD, Lincoff AM, Gibson CM, Pollack CV, Montalescot G, Mahaffey KW, Kleiman NS, Goodman SG, Amine M, Angiolillo DJ, Becker RC, Chew DP, French WJ, Leisch F, Parikh KH, Skerjanec S, Bhatt DL. Platelet inhibition with cangrelor in patients undergoing PCI. N Engl J Med. 2009 Dec 10; 361(24):2318-29. PMID: 19915221.
      Citations: 108     Fields:    Translation:Humans
    257. Bhatt DL, Lincoff AM, Gibson CM, Stone GW, McNulty S, Montalescot G, Kleiman NS, Goodman SG, White HD, Mahaffey KW, Pollack CV, Manoukian SV, Widimsky P, Chew DP, Cura F, Manukov I, Tousek F, Jafar MZ, Arneja J, Skerjanec S, Harrington RA, CHAMPION PLATFORM Investigators. Intravenous platelet blockade with cangrelor during PCI. N Engl J Med. 2009 Dec 10; 361(24):2330-41. PMID: 19915222.
      Citations: 117     Fields:    Translation:Humans
    258. Putney DR, Kleiman NS, Fromm RE, Buergler JM. Impact of computerized dosing on eptifibatide-associated bleeding and mortality. Am Heart J. 2009 Dec; 158(6):1018-23. PMID: 19958870.
      Citations:    Fields:    Translation:Humans
    259. Lindsey JB, Marso SP, Pencina M, Stolker JM, Kennedy KF, Rihal C, Barsness G, Piana RN, Goldberg SL, Cutlip DE, Kleiman NS, Cohen DJ, EVENT Registry Investigators. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry. JACC Cardiovasc Interv. 2009 Nov; 2(11):1074-82. PMID: 19926047.
      Citations: 21     Fields:    Translation:Humans
    260. Novack V, Cutlip D, Kleiman N, Pencina M, Mauri L, Yen CH, Berger P, Goldberg S, Kellett M, Waksman R, Hong M, Raizner AE, Cohen DJ. In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv. 2009 Aug; 2(8):767-75. PMID: 19695546.
      Citations:    Fields:    Translation:Humans
    261. Holmes DR, Kereiakes DJ, Kleiman NS, Moliterno DJ, Patti G, Grines CL. Combining antiplatelet and anticoagulant therapies. J Am Coll Cardiol. 2009 Jul 07; 54(2):95-109. PMID: 19573725.
      Citations: 23     Fields:    Translation:Humans
    262. Novack V, Tsyvine D, Cohen DJ, Pencina M, Dubin J, Dehghani H, Kleiman NS, Cutlip DE. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry. Catheter Cardiovasc Interv. 2009 Jun 01; 73(7):874-80. PMID: 19180665.
      Citations: 2     Fields:    Translation:Humans
    263. Ben-Dor I, Kleiman NS, Lev E. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy. Am J Cardiol. 2009 Jul 15; 104(2):227-33. PMID: 19576352.
      Citations: 25     Fields:    Translation:HumansCells
    264. Little SH, Kleiman N, Guthikonda S. Percutaneous paravalvular repair: guidance using live 3-dimensional transesophageal echocardiography. J Am Coll Cardiol. 2009 Apr 21; 53(16):1467. PMID: 19371832.
      Citations: 1     Fields:    Translation:Humans
    265. Bhatt DL, Peterson ED, Harrington RA, Ou FS, Cannon CP, Gibson CM, Kleiman NS, Brindis RG, Peacock WF, Brener SJ, Menon V, Smith SC, Pollack CV, Gibler WB, Ohman EM, Roe MT, CRUSADE Investigators. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. Eur Heart J. 2009 May; 30(10):1195-202. PMID: 19339264.
      Citations: 34     Fields:    Translation:Humans
    266. Crespo EM, Oliveira GB, Honeycutt EF, Becker RC, Berger PB, Moliterno DJ, Anstrom KJ, Abrams CS, Kleiman NS, Moll S, Rice L, Rodgers JE, Steinhubl SR, Tapson VF, Granger CB, Ohman EM, CATCH Registry Investigators. Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry. Am Heart J. 2009 Apr; 157(4):651-7. PMID: 19332191.
      Citations: 8     Fields:    Translation:Humans
    267. Latif F, Kleiman NS, Cohen DJ, Pencina MJ, Yen CH, Cutlip DE, Moliterno DJ, Nassif D, Lopez JJ, Saucedo JF, EVENT Investigators. In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv. 2009 Jan; 2(1):37-45. PMID: 19463396.
      Citations: 42     Fields:    Translation:Humans
    268. Kleiman NS. Searching for the ceiling: new reflections on the disposition and metabolism of clopidogrel. JACC Cardiovasc Interv. 2008 Dec; 1(6):628-30. PMID: 19463376.
      Citations:    Fields:    Translation:HumansCells
    269. Kleiman NS. Clopidogrel and calcium-channel antagonists: another drug-drug interaction for the ever-wary clinician? J Am Coll Cardiol. 2008 Nov 04; 52(19):1564-6. PMID: 19007593.
      Citations: 1     Fields:    Translation:Humans
    270. Vaduganathan M, Alviar CL, Arikan ME, Tellez A, Guthikonda S, DeLao T, Granada JF, Kleiman NS, Ballantyne CM, Lev EI. Platelet reactivity and response to aspirin in subjects with the metabolic syndrome. Am Heart J. 2008 Nov; 156(5):1002.e1-1002.e7. PMID: 19061719.
      Citations: 20     Fields:    Translation:HumansCells
    271. Little SH, Zekry SB, Zoghbi WA, Kleiman NS, Guthikonda S. Three-dimensional transesophageal echocardiogram provides real-time guidance during percutaneous paravalvular mitral repair. Circ Heart Fail. 2008 Nov; 1(4):293-4. PMID: 19808306.
      Citations:    Fields:    Translation:Humans
    272. Guthikonda S, Alviar CL, Vaduganathan M, Arikan M, Tellez A, DeLao T, Granada JF, Dong JF, Kleiman NS, Lev EI. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol. 2008 Aug 26; 52(9):743-9. PMID: 18718422.
      Citations: 85     Fields:    Translation:Humans
    273. Garg R, Tellez A, Alviar C, Granada J, Kleiman NS, Lev EI. The effect of percutaneous coronary intervention on inflammatory response and endothelial progenitor cell recruitment. Catheter Cardiovasc Interv. 2008 Aug 01; 72(2):205-9. PMID: 18651648.
      Citations: 10     Fields:    Translation:HumansCells
    274. Jeremias A, Kleiman NS, Nassif D, Hsieh WH, Pencina M, Maresh K, Parikh M, Cutlip DE, Waksman R, Goldberg S, Berger PB, Cohen DJ, Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) Registry Investigators. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry. Circulation. 2008 Aug 05; 118(6):632-8. PMID: 18645057.
      Citations: 14     Fields:    Translation:Humans
    275. Kleiman NS. Should Prasugrel or Clopidogrel Be Used in Patients with ACS? Curr Cardiol Rep. 2008 Jul; 10(4):301-2. PMID: 18611364.
      Citations:    Fields:    
    276. Guthikonda S, Mangalpally K, Vaduganathan M, Patel R, Delao T, Bergeron AL, Dong JF, Lev EI, Kleiman NS. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy. Thromb Haemost. 2008 Jul; 100(1):83-9. PMID: 18612542.
      Citations: 4     Fields:    Translation:HumansCellsCTClinical Trials
    277. Kleiman NS, Freedman JE, Tracy PB, Furie BC, Bray PF, Rao SV, Phillips DR, Storey RF, Rusconi CP, French PA, Steinhubl SR, Becker RC. Platelets: developmental biology, physiology, and translatable platforms for preclinical investigation and drug development. Platelets. 2008 Jun; 19(4):239-51. PMID: 18569859.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    278. Chan MY, Cohen MG, Dyke CK, Myles SK, Aberle LG, Lin M, Walder J, Steinhubl SR, Gilchrist IC, Kleiman NS, Vorchheimer DA, Chronos N, Melloni C, Alexander JH, Harrington RA, Tonkens RM, Becker RC, Rusconi CP. Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease. Circulation. 2008 Jun 03; 117(22):2865-74. PMID: 18506005.
      Citations: 42     Fields:    Translation:HumansCTClinical Trials
    279. Kleiman NS. Will measuring vasodilator-stimulated phosphoprotein phosphorylation help us optimize the loading dose of clopidogrel? J Am Coll Cardiol. 2008 Apr 08; 51(14):1412-4. PMID: 18387445.
      Citations:    Fields:    Translation:HumansCells
    280. Direct Inhibition of delta-Protein Kinase C Enzyme to Limit Total Infarct Size in Acute Myocardial I, Bates E, Bode C, Costa M, Gibson CM, Granger C, Green C, Grimes K, Harrington R, Huber K, Kleiman N, Mochly-Rosen D, Roe M, Sadowski Z, Solomon S, Widimsky P. Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Circulation. 2008 Feb 19; 117(7):886-96. PMID: 18250271.
      Citations: 66     Fields:    Translation:Humans
    281. Mahaffey KW, Yang Q, Pieper KS, Antman EM, White HD, Goodman SG, Cohen M, Kleiman NS, Langer A, Aylward PE, Col JJ, Reist C, Ferguson JJ, Califf RM, SYNERGY Trial Investigators. Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial. J Gen Intern Med. 2008 Mar; 23(3):310-6. PMID: 18196350; PMCID: PMC2359476.
      Citations: 7     Fields:    Translation:Humans
    282. Oliveira GB, Crespo EM, Becker RC, Honeycutt EF, Abrams CS, Anstrom KJ, Berger PB, Davidson-Ray LD, Eisenstein EL, Kleiman NS, Moliterno DJ, Moll S, Rice L, Rodgers JE, Steinhubl SR, Tapson VF, Ohman EM, Granger CB, Complications After Thrombocytopenia Caused by Heparin (CATCH) Registry Investigators. Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. Arch Intern Med. 2008 Jan 14; 168(1):94-102. PMID: 18195201.
      Citations: 21     Fields:    Translation:HumansCells
    283. Buergler JM, Alam S, Spencer W, Kleiman NS, Melendez Y, Franklin J, Nagueh SF. Initial experience with alcohol septal ablation using a novel magnetic navigation system. J Interv Cardiol. 2007 Dec; 20(6):559-63. PMID: 18042061.
      Citations:    Fields:    Translation:Humans
    284. Tricoci P, Lokhnygina Y, Berdan LG, Steinhubl SR, Gulba DC, White HD, Kleiman NS, Aylward PE, Langer A, Califf RM, Ferguson JJ, Antman EM, Newby LK, Harrington RA, Goodman SG, Mahaffey KW. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. Circulation. 2007 Dec 04; 116(23):2669-77. PMID: 18025532.
      Citations: 13     Fields:    Translation:Humans
    285. Lev EI, Arikan ME, Vaduganathan M, Alviar CL, Tellez A, Mathuria N, Builes A, Granada JF, del Conde I, Kleiman NS. Effect of caffeine on platelet inhibition by clopidogrel in healthy subjects and patients with coronary artery disease. Am Heart J. 2007 Oct; 154(4):694.e1-7. PMID: 17892993.
      Citations: 6     Fields:    Translation:Humans
    286. Patel RT, Lev EI, Vaduganathan M, Guthikonda S, Bergeron A, Maresh K, Dong JF, Kleiman NS. Platelet reactivity among Asian Indians and Caucasians. Platelets. 2007 Jun; 18(4):261-5. PMID: 17538846.
      Citations: 3     Fields:    Translation:HumansCells
    287. Win HK, Caldera AE, Maresh K, Lopez J, Rihal CS, Parikh MA, Granada JF, Marulkar S, Nassif D, Cohen DJ, Kleiman NS, EVENT Registry Investigators. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA. 2007 May 09; 297(18):2001-9. PMID: 17488965.
      Citations: 41     Fields:    Translation:HumansPHPublic Health
    288. Grossman PM, Mendelsohn F, Henry TD, Hermiller JB, Litt M, Saucedo JF, Weiss RJ, Kandzari DE, Kleiman N, Anderson RD, Gottlieb D, Karlsberg R, Snell J, Rocha-Singh K. Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease. Am Heart J. 2007 May; 153(5):874-80. PMID: 17452167.
      Citations: 27     Fields:    Translation:HumansCTClinical Trials
    289. Cotter G, Reynolds HR, Alexander JH, Ramanathan K, Stebbins AL, Hathaway D, Farkouh ME, Ohman EM, Baran DA, Prondzinsky R, Panza JA, Cantor WJ, Vered Z, Buller CE, Kleiman NS, Webb JG, Holmes DR, Parrillo JE, Hazen SL, Gross SS, Harrington RA, Hochman JS, SHould we inhibit nitric Oxide synthase in Cardiogenic shocK 2 (SHOCK-2) investigators, Dzav?k V. Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study. Eur Heart J. 2007 May; 28(9):1109-16. PMID: 17459901.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    290. Lev EI, Ramchandani M, Garg R, Wojciechowski Z, Builes A, Vaduganathan M, Tripathy U, Kleiman NS. Response to aspirin and clopidogrel in patients scheduled to undergo cardiovascular surgery. J Thromb Thrombolysis. 2007 Aug; 24(1):15-21. PMID: 17277998.
      Citations: 1     Fields:    Translation:Humans
    291. Schweiger MJ, Chambers CE, Davidson CJ, Zhang S, Blankenship J, Bhalla NP, Block PC, Dervan JP, Gasperetti C, Gerber L, Kleiman NS, Krone RJ, Phillips WJ, Siegel RM, Uretsky BF, Laskey WK. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv. 2007 Jan; 69(1):135-40. PMID: 17139671.
      Citations: 32     Fields:    Translation:Humans
    292. Lev EI, Alviar CL, Arikan ME, Dave BP, Granada JF, DeLao T, Tellez A, Maresh K, Kleiman NS. Platelet reactivity in patients with subacute stent thrombosis compared with non-stent-related acute myocardial infarction. Am Heart J. 2007 Jan; 153(1):41.e1-6. PMID: 17174635.
      Citations: 4     Fields:    Translation:Humans
    293. Cantor WJ, Mahaffey KW, Huang Z, Das P, Gulba DC, Glezer S, Gallo R, Ducas J, Cohen M, Antman EM, Langer A, Kleiman NS, White HD, Chisholm RJ, Harrington RA, Ferguson JJ, Califf RM, Goodman SG. Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal. Catheter Cardiovasc Interv. 2007 Jan; 69(1):73-83. PMID: 17139670.
      Citations: 13     Fields:    Translation:Humans
    294. White HD, Kleiman NS, Mahaffey KW, Lokhnygina Y, Pieper KS, Chiswell K, Cohen M, Harrington RA, Chew DP, Petersen JL, Berdan LG, Aylward PE, Nessel CC, Ferguson JJ, Califf RM. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial. Am Heart J. 2006 Dec; 152(6):1042-50. PMID: 17161049.
      Citations: 15     Fields:    Translation:Humans
    295. Lev EI, Ramabadran RS, Guthikonda S, Patel R, Kleiman A, Granada JF, DeLao T, Kleiman NS. Effect of ranitidine on the antiplatelet effects of aspirin in healthy human subjects. Am J Cardiol. 2007 Jan 01; 99(1):124-8. PMID: 17196475.
      Citations: 2     Fields:    Translation:HumansCells
    296. Kleiman NS. Measuring troponin elevation after percutaneous coronary intervention: ready for prime time? J Am Coll Cardiol. 2006 Nov 07; 48(9):1771-3. PMID: 17084248.
      Citations: 2     Fields:    Translation:Humans
    297. Patel MR, Chen AY, Peterson ED, Newby LK, Pollack CV, Brindis RG, Gibson CM, Kleiman NS, Saucedo JF, Bhatt DL, Gibler WB, Ohman EM, Harrington RA, Roe MT. Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative. Am Heart J. 2006 Oct; 152(4):641-7. PMID: 16996828.
      Citations: 48     Fields:    Translation:Humans
    298. Lev EI, Estrov Z, Aboulfatova K, Harris D, Granada JF, Alviar C, Kleiman NS, Dong JF. Potential role of activated platelets in homing of human endothelial progenitor cells to subendothelial matrix. Thromb Haemost. 2006 Oct; 96(4):498-504. PMID: 17003929.
      Citations: 22     Fields:    Translation:HumansCells
    299. Rajagopal V, Lincoff AM, Cohen DJ, Gurm HS, Hu T, Desmet WJ, Kleiman NS, Bittl JA, Feit F, Topol EJ. Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial. Am Heart J. 2006 Jul; 152(1):149-54. PMID: 16824845.
      Citations: 5     Fields:    Translation:Humans
    300. Exaire JE, Butman SM, Ebrahimi R, Kleiman NS, Harrington RA, Schweiger MJ, Bittl JA, Wolski K, Topol EJ, Lincoff AM, REPLACE-2 Investigators. Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial. Am Heart J. 2006 Jul; 152(1):157-63. PMID: 16824849.
      Citations: 4     Fields:    Translation:Humans
    301. Lev EI, Tayyan N, Raizner AE, Solomon SL, Simmons D, Kleiman NS. Initial impact of drug-eluting stent use on the spectrum of patients undergoing percutaneous coronary intervention. Coron Artery Dis. 2006 May; 17(4):379-84. PMID: 16707962.
      Citations: 1     Fields:    Translation:Humans
    302. Blankenship JC, Haldis T, Feit F, Hu T, Kleiman NS, Topol EJ, Lincoff AM, REPLACE-2 Investigators. Angiographic adverse events, creatine kinase-MB elevation, and ischemic end points complicating percutaneous coronary intervention (a REPLACE-2 substudy). Am J Cardiol. 2006 Jun 01; 97(11):1591-6. PMID: 16728220.
      Citations: 6     Fields:    Translation:Humans
    303. Lev EI, Patel RT, Guthikonda S, Lopez D, Bray PF, Kleiman NS. Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel. Thromb Res. 2007; 119(3):355-60. PMID: 16581111.
      Citations: 38     Fields:    Translation:HumansCTClinical Trials
    304. Lev EI, Patel R, Karim A, Kleiman A, Badimon JJ, Kleiman NS. Anti-thrombotic effect of bivalirudin compared with eptifibatide and unfractionated heparin in diabetic patients: an ex vivo human study. Thromb Haemost. 2006 Mar; 95(3):441-6. PMID: 16525571.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    305. Ellis TC, Lev E, Yazbek NF, Kleiman NS. Therapeutic strategies for cardiogenic shock, 2006. Curr Treat Options Cardiovasc Med. 2006 Feb; 8(1):79-94. PMID: 16401386.
      Citations:    
    306. Atmakuri SR, Lev EI, Alviar C, Ibarra E, Raizner AE, Solomon SL, Kleiman NS. Initial experience with a magnetic navigation system for percutaneous coronary intervention in complex coronary artery lesions. J Am Coll Cardiol. 2006 Feb 07; 47(3):515-21. PMID: 16458129.
      Citations: 5     Fields:    Translation:Humans
    307. Guthikonda S, Kleiman NS. Is aspirin resistance valid? Future Cardiol. 2006 Jan; 2(1):1-4. PMID: 19804124.
      Citations:    Fields:    
    308. Lev EI, Patel RT, Maresh KJ, Guthikonda S, Granada J, DeLao T, Bray PF, Kleiman NS. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol. 2006 Jan 03; 47(1):27-33. PMID: 16386660.
      Citations: 79     Fields:    Translation:Humans
    309. Mahaffey KW, Cohen M, Garg J, Antman E, Kleiman NS, Goodman SG, Berdan LG, Reist CJ, Langer A, White HD, Aylward PE, Col JJ, Ferguson JJ, Califf RM, SYNERGY Trial Investigators. High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial. JAMA. 2005 Nov 23; 294(20):2594-600. PMID: 16304073.
      Citations: 12     Fields:    Translation:Humans
    310. Jacob S, Cohen DJ, Massaro J, Niemyski P, Maresh K, Kleiman N, EVENT Investigators. Design of a registry to characterize "real-world" outcomes of percutaneous coronary revascularization in the drug-eluting stent era. Am Heart J. 2005 Nov; 150(5):887-92. PMID: 16290954.
      Citations: 1     Fields:    Translation:Humans
    311. Lev EI, Kleiman NS, Birnbaum Y, Harris D, Korbling M, Estrov Z. Circulating endothelial progenitor cells and coronary collaterals in patients with non-ST segment elevation myocardial infarction. J Vasc Res. 2005 Sep-Oct; 42(5):408-14. PMID: 16088214.
      Citations: 17     Fields:    Translation:HumansCells
    312. Guthikonda S, Lev EI, Kleiman NS. Resistance to antiplatelet therapy. Curr Cardiol Rep. 2005 Jul; 7(4):242-8. PMID: 15987620.
      Citations: 2     Fields:    Translation:HumansCells
    313. Kleiman NS. Could clopidogrel's platelet inhibition be enhanced by an increased loading dose and eptifibatide? Nat Clin Pract Cardiovasc Med. 2005 Jul; 2(7):344-5. PMID: 16265559.
      Citations:    Fields:    Translation:HumansPHPublic Health
    314. Gurm HS, Sarembock IJ, Kereiakes DJ, Young JJ, Harrington RA, Kleiman N, Feit F, Wolski K, Bittl JA, Wilcox R, Topol EJ, Lincoff AM. Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial. J Am Coll Cardiol. 2005 Jun 21; 45(12):1932-8. PMID: 15963389.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    315. Mahaffey KW, Roe MT, Kilaru R, French JK, Alexander JH, Berdan LG, Van De Werf F, Simoons ML, Weaver WD, White HD, Lincoff AM, Kleiman NS, Topol EJ, Harrington RA. Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes. Am J Cardiol. 2005 Jun 15; 95(12):1404-8. PMID: 15950560.
      Citations: 2     Fields:    Translation:Humans
    316. Buergler JM, Maliszewski CR, Broekman MJ, Kaluza GL, Schulz DG, Marcus AJ, Raizner AE, Kleiman NS, Ali NM. Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model. J Thromb Thrombolysis. 2005 Apr; 19(2):115-22. PMID: 16052302.
      Citations: 10     Fields:    Translation:HumansAnimals
    317. Exaire JE, Tcheng JE, Kereiakes DJ, Kleiman NS, Applegate RJ, Moliterno DJ, ELECT Investigators. Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel. Catheter Cardiovasc Interv. 2005 Mar; 64(3):369-72. PMID: 15736260.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    318. del Conde I, Nabi F, Thiagarajan P, Kleiman NS, Tonda R, L?pez JA. Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes. Arterioscler Thromb Vasc Biol. 2005 May; 25(5):1065-70. PMID: 15705928.
      Citations: 23     Fields:    Translation:HumansCells
    319. Ohman EM, Granger CB, Rice L, Abrams CS, Becker RC, Berger PB, Kleiman NS, Moliterno D, Moll S, Rodgers JE, Steinhubl SS, Tapson VF, Sinnaeve P, Anstrom KJ, Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry. Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee. J Thromb Thrombolysis. 2005 Feb; 19(1):11-9. PMID: 15976962.
      Citations: 3     Fields:    Translation:Humans
    320. Prahash A, Kleiman N, Espada R, Dokainish H. Idiopathic sinus of Valsalva to right atrial fistula: an unusual origin of right-sided heart failure. J Am Soc Echocardiogr. 2004 Dec; 17(12):1317-8. PMID: 15562275.
      Citations: 1     Fields:    Translation:Humans
    321. Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, Greenbaum AB, Berger PB, Cannon CP, Cohen DJ, Gibson CM, Saucedo JF, Kleiman NS, Hochman JS, Boden WE, Brindis RG, Peacock WF, Smith SC, Pollack CV, Gibler WB, Ohman EM, CRUSADE Investigators. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA. 2004 Nov 03; 292(17):2096-104. PMID: 15523070.
      Citations: 96     Fields:    Translation:Humans
    322. Cox DS, Kleiman NS, Boyle DA, Aluri J, Parchman LG, Holdbrook F, Fossler MJ. Pharmacokinetics and pharmacodynamics of argatroban in combination with a platelet glycoprotein IIB/IIIA receptor antagonist in patients undergoing percutaneous coronary intervention. J Clin Pharmacol. 2004 Sep; 44(9):981-90. PMID: 15317826.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    323. Lincoff AM, Kleiman NS, Kereiakes DJ, Feit F, Bittl JA, Jackman JD, Sarembock IJ, Cohen DJ, Spriggs D, Ebrahimi R, Keren G, Carr J, Cohen EA, Betriu A, Desmet W, Rutsch W, Wilcox RG, de Feyter PJ, Vahanian A, Topol EJ, REPLACE-2 Investigators. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. JAMA. 2004 Aug 11; 292(6):696-703. PMID: 15304466.
      Citations: 49     Fields:    Translation:HumansCTClinical Trials
    324. Petersen JL, Mahaffey KW, Becker RC, Goodman SG, Kleiman NS, Marian AJ, Stone GW, Lansky AJ, Lincoff AM, Hazen SL, Nessel CC, Toro-Figueroa L, Tate L, Reist CJ, Cohen M, Califf RM, Ferguson JJ, SYNERGY Library. Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY Library. Am Heart J. 2004 Aug; 148(2):269-76. PMID: 15308996.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    325. Jang IK, Lewis BE, Matthai WH, Kleiman NS. Argatroban anticoagulation in conjunction with glycoprotein IIb/IIIa inhibition in patients undergoing percutaneous coronary intervention: an open-label, nonrandomized pilot study. J Thromb Thrombolysis. 2004 Aug; 18(1):31-7. PMID: 15744551.
      Citations: 10     Fields:    Translation:Humans
    326. Rajagopal V, Gurm HS, Bhatt DL, Lincoff AM, Tcheng JE, Kereiakes DJ, Kleiman NS, Jia G, Topol EJ. Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortality. Am J Cardiol. 2004 Jul 15; 94(2):190-2. PMID: 15246898.
      Citations: 6     Fields:    Translation:Humans
    327. Ferguson JJ, Califf RM, Antman EM, Cohen M, Grines CL, Goodman S, Kereiakes DJ, Langer A, Mahaffey KW, Nessel CC, Armstrong PW, Avezum A, Aylward P, Becker RC, Biasucci L, Borzak S, Col J, Frey MJ, Fry E, Gulba DC, Guneri S, Gurfinkel E, Harrington R, Hochman JS, Kleiman NS, Leon MB, Lopez-Sendon JL, Pepine CJ, Ruzyllo W, Steinhubl SR, Teirstein PS, Toro-Figueroa L, White H, SYNERGY Trial Investigators. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA. 2004 Jul 07; 292(1):45-54. PMID: 15238590.
      Citations: 123     Fields:    Translation:HumansCTClinical Trials
    328. Chang WC, Boersma E, Granger CB, Harrington RA, Califf RM, Simoons ML, Kleiman NS, Armstrong PW, GUSTO-IIb and PURSUIT Investigators. Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT. Am Heart J. 2004 Jul; 148(1):62-71. PMID: 15215793.
      Citations: 10     Fields:    Translation:Humans
    329. Kleiman NS. Platelets, the cardiologist, and coronary artery disease: moving beyond aggregation. J Am Coll Cardiol. 2004 Jun 02; 43(11):1989-91. PMID: 15172402.
      Citations:    Fields:    Translation:HumansCells
    330. Labinaz M, Kaul P, Harrington RA, Chang WC, Kleiman NS, Simoons ML, Boersma E, Akkerhuis KM, Califf RM, Armstrong PW, PURSUIT investigators. Six-month outcomes of percutaneous coronary balloon angioplasty in acute coronary syndromes: Results from the PURSUIT trial. Can J Cardiol. 2004 Jun; 20(8):773-8. PMID: 15229770.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    331. Dakik HA, Koubeissi Z, Kleiman NS, Nasrallah A, Sawaya J, Gharzuddine W, Tamim H, Shaar K, Alam S. Acute myocardial infarction: clinical characteristics, management and outcome in a university medical centre in a developing Middle Eastern country. Can J Cardiol. 2004 Jun; 20(8):789-93. PMID: 15229760.
      Citations: 5     Fields:    Translation:Humans
    332. Lincoff AM, Bittl JA, Kleiman NS, Sarembock IJ, Jackman JD, Mehta S, Tannenbaum MA, Niederman AL, Bachinsky WB, Tift-Mann J, Parker HG, Kereiakes DJ, Harrington RA, Feit F, Maierson ES, Chew DP, Topol EJ, REPLACE-1 Investigators. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial). Am J Cardiol. 2004 May 01; 93(9):1092-6. PMID: 15110198.
      Citations: 41     Fields:    Translation:HumansCTClinical Trials
    333. Quinn MJ, Aronow HD, Califf RM, Bhatt DL, Sapp S, Kleiman NS, Harrington RA, Kong DF, Kandzari DE, Topol EJ. Aspirin dose and six-month outcome after an acute coronary syndrome. J Am Coll Cardiol. 2004 Mar 17; 43(6):972-8. PMID: 15028352.
      Citations: 5     Fields:    Translation:Humans
    334. Pieper KS, Tsiatis AA, Davidian M, Hasselblad V, Kleiman NS, Boersma E, Chang WC, Griffin J, Armstrong PW, Califf RM, Harrington RA. Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods. Circulation. 2004 Feb 10; 109(5):641-6. PMID: 14769687.
      Citations: 6     Fields:    Translation:Humans
    335. Conde ID, Kleiman NS. Patient-specific antiplatelet therapy. J Thromb Thrombolysis. 2004 Feb; 17(1):63-77. PMID: 15277789.
      Citations:    Fields:    Translation:Humans
    336. Yazbek NF, Kleiman NS. Therapeutic Strategies for Cardiogenic Shock. Curr Treat Options Cardiovasc Med. 2004 Feb; 6(1):29-41. PMID: 15023282.
      Citations:    
    337. Granada JF, Kleiman NS. Therapeutic use of intravenous eptifibatide in patients undergoing percutaneous coronary intervention: acute coronary syndromes and elective stenting. Am J Cardiovasc Drugs. 2004; 4(1):31-41. PMID: 14967064.
      Citations: 5     Fields:    Translation:Humans
    338. Urquidi-Macdonald M, Mager DE, Mascelli MA, Frederick B, Freedman J, Fitzgerald DJ, Kleiman NS, Abernethy DR. Abciximab pharmacodynamic model with neural networks used to integrate sources of patient variability. Clin Pharmacol Ther. 2004 Jan; 75(1):60-9. PMID: 14749692.
      Citations: 1     Fields:    Translation:Humans
    339. Grines C, Rubanyi GM, Kleiman NS, Marrott P, Watkins MW. Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease. Am J Cardiol. 2003 Nov 07; 92(9B):24N-31N. PMID: 14615023.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    340. Kleiman NS, Patel NC, Allen KB, Simons M, Griffin E, Dzau VJ, Yl?-Herttuala S. Evolving revascularization approaches for myocardial ischemia. Am J Cardiol. 2003 Nov 07; 92(9B):9N-17N. PMID: 14615021.
      Citations: 5     Fields:    Translation:HumansAnimals
    341. Grines CL, Watkins MW, Mahmarian JJ, Iskandrian AE, Rade JJ, Marrott P, Pratt C, Kleiman N, Angiogene GENe Therapy (AGENT-2) Study Group. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J Am Coll Cardiol. 2003 Oct 15; 42(8):1339-47. PMID: 14563572.
      Citations: 56     Fields:    Translation:HumansCellsCTClinical Trials
    342. Mager DE, Mascelli MA, Kleiman NS, Fitzgerald DJ, Abernethy DR. Simultaneous modeling of abciximab plasma concentrations and ex vivo pharmacodynamics in patients undergoing coronary angioplasty. J Pharmacol Exp Ther. 2003 Dec; 307(3):969-76. PMID: 14534354.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    343. Conde ID, Kleiman NS. Arterial thrombosis for the interventional cardiologist: from adhesion molecules and coagulation factors to clinical therapeutics. Catheter Cardiovasc Interv. 2003 Oct; 60(2):236-46. PMID: 14517933.
      Citations: 4     Fields:    Translation:Humans
    344. Moliterno DJ, Hermiller JB, Kereiakes DJ, Yow E, Applegate RJ, Braden GA, Dippel EJ, Furman MI, Grines CL, Kleiman NS, Levine GN, Mann T, Nair RN, Stine RA, Yacubov SJ, Tcheng JE, ELECT Investigators. A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study. J Am Coll Cardiol. 2003 Sep 17; 42(6):1132-9. PMID: 13678943.
      Citations: 7     Fields:    Translation:Humans
    345. Yazbek N, Bapat A, Kleiman N. Platelet abnormalities in diabetes mellitus. Coron Artery Dis. 2003 Aug; 14(5):365-71. PMID: 12878901.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    346. Becker R, Butenas S, Carr M, Jaffer F, Kleiman NS, Marmur JD, Schneider DJ, Spiess BD, Steinhubl SR, Weitz JI. Bivalirudin, thrombin and platelets: clinical implications and future directions. J Invasive Cardiol. 2003 Aug; Suppl:2-15. PMID: 23570139.
      Citations:    Fields:    Translation:HumansAnimalsCells
    347. Conde ID, Kleiman NS. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med. 2003 Jun 19; 348(25):2575-7; author reply 2575-7. PMID: 12816111.
      Citations: 5     Fields:    Translation:Humans
    348. Kleiman NS. Combination therapy for acute myocardial infarction: will it survive? J Am Coll Cardiol. 2003 Apr 16; 41(8):1261-3. PMID: 12706918.
      Citations:    Fields:    Translation:HumansAnimals
    349. Nguyen-Ho P, Kleiman NS, Verani MS. Acute myocardial infarction and cardiac arrest in a patient receiving paclitaxel. Can J Cardiol. 2003 Mar 15; 19(3):300-2. PMID: 12677287.
      Citations: 2     Fields:    Translation:Humans
    350. Lincoff AM, Bittl JA, Harrington RA, Feit F, Kleiman NS, Jackman JD, Sarembock IJ, Cohen DJ, Spriggs D, Ebrahimi R, Keren G, Carr J, Cohen EA, Betriu A, Desmet W, Kereiakes DJ, Rutsch W, Wilcox RG, de Feyter PJ, Vahanian A, Topol EJ, REPLACE-2 Investigators. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA. 2003 Feb 19; 289(7):853-63. PMID: 12588269.
      Citations: 165     Fields:    Translation:HumansCTClinical Trials
    351. Fernandes LS, Conde ID, Wayne Smith C, Kansas GS, Snapp KR, Bennet N, Ballantyne C, McIntire LV, O'Brian Smith E, Klem JA, Mathew S, Frangogiannis N, Turner NA, Maresh KJ, Kleiman NS. Platelet-monocyte complex formation: effect of blocking PSGL-1 alone, and in combination with alphaIIbbeta3 and alphaMbeta2, in coronary stenting. Thromb Res. 2003; 111(3):171-7. PMID: 14678816.
      Citations: 13     Fields:    Translation:HumansCells
    352. Topol EJ, Lincoff AM, Kereiakes DJ, Kleiman NS, Cohen EA, Ferguson JJ, Tcheng JE, Sapp S, Califf RM. Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization. Am J Med. 2002 Jul; 113(1):1-6. PMID: 12106616.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    353. Dyke CK, Becker RC, Kleiman NS, Hochman JS, Bovill EG, Lincoff AM, Gerstenblith G, Dzavik V, Gardner LH, Hasselblad V, Zillman LA, Shimoto Y, Robertson TL, Kunitada S, Armstrong PW, Harrington RA. First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation. Circulation. 2002 May 21; 105(20):2385-91. PMID: 12021225.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    354. Lincoff AM, Kleiman NS, Kottke-Marchant K, Maierson ES, Maresh K, Wolski KE, Topol EJ. Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET). Am Heart J. 2002 May; 143(5):847-53. PMID: 12040347.
      Citations: 30     Fields:    Translation:HumansCTClinical Trials
    355. Kleiman NS, Klem J, Fernandes LS, Rubin H, Challa S, Solomon S, Maresh K, Arora U, Klem E, Buergler J, Mathew S, Browning A, DeLao T. Pharmacodynamic profile of the direct thrombin antagonist bivalirudin given in combination with the glycoprotein IIb/IIIa antagonist eptifibatide. Am Heart J. 2002 Apr; 143(4):585-93. PMID: 11923794.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    356. Mazur W, Kaluza GL, Sapp S, Balog C, Topol EJ, Mark DB, Ellis SG, Kereiakes DJ, Lincoff AM, Kleiman NS. Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists. Am Heart J. 2002 Apr; 143(4):594-601. PMID: 11923795.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    357. Abernethy DR, Pezzullo J, Mascelli MA, Frederick B, Kleiman NS, Freedman J. Pharmacodynamics of abciximab during angioplasty: comparison to healthy subjects. Clin Pharmacol Ther. 2002 Mar; 71(3):186-95. PMID: 11907493.
      Citations: 7     Fields:    Translation:Humans
    358. Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, Udelson JE, Gervino EV, Pike M, Whitehouse MJ, Moon T, Chronos NA. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation. 2002 Feb 19; 105(7):788-93. PMID: 11854116.
      Citations: 174     Fields:    Translation:HumansCTClinical Trials
    359. Mahaffey KW, Harrington RA, Akkerhuis M, Kleiman NS, Berdan LG, Crenshaw BS, Tardiff BE, Granger CB, DeJong I, Bhapkar M, Widimsky P, Lee KL, Deckers JW, Simoons ML, Topol EJ, Califf RM, For the PURSUIT Investigators , Corbalon R. Systematic adjudication of myocardial infarction end-points in an international clinical trial. Curr Control Trials Cardiovasc Med. 2001 Jul 17; 2(4):180-186. PMID: 11806793; PMCID: PMC57749.
      Citations: 25     
    360. Mahaffey KW, Harrington RA, Akkerhuis M, Kleiman NS, Berdan LG, Crenshaw BS, Tardiff BE, Granger CB, DeJong I, Bhapkar M, Widimsky P, Lee KL, Deckers JW, Simoons ML, Topol EJ, Califf RM, For the PURSUIT Investigators , Corbalon R. Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study. Curr Control Trials Cardiovasc Med. 2001 Jul 17; 2(4):187-194. PMID: 11806794; PMCID: PMC57750.
      Citations: 23     
    KLEIMAN's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (670)
    Explore
    _
    Co-Authors (30)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _